{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "gpuType": "L4",
      "authorship_tag": "ABX9TyMWiPZn1DN/KEtvPncNmbiD",
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/louisdennington-design/decision-tree-dissertation/blob/main/the_state_manager.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Current issue needing attention: list of fields for structured JSON guideline and patient schema are currently repeated across several places here and in llm_makes_json, needing parallel updates and vulnerable to errors. Compile one list of keys that can be shared across the following?:\n",
        "\n",
        "\n",
        "\n",
        "*   llm_makes_json -> def construct_prompt()\n",
        "*   llm_makes_json -> def orchestrate_create_json()\n",
        "*   the_state_manager -> def extract_patient_facts()\n",
        "\n"
      ],
      "metadata": {
        "id": "kTdfZCG9tD7a"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Mount Google Drive\n",
        "\n",
        "from google.colab import drive\n",
        "drive.mount('/content/drive', force_remount = True)"
      ],
      "metadata": {
        "id": "O8nDQhbiIU1w",
        "outputId": "7264ee92-77c9-49c7-9517-6f6cdf6d3c6a",
        "colab": {
          "base_uri": "https://localhost:8080/"
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Mounted at /content/drive\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Import packages\n",
        "\n",
        "!pip install -q streamlit\n",
        "!pip install -q streamlit-chat\n",
        "\n",
        "import os\n",
        "import json\n",
        "from transformers import AutoModelForCausalLM, AutoTokenizer\n",
        "import streamlit as st\n",
        "from streamlit_chat import message"
      ],
      "metadata": {
        "id": "DYIc3r4HIXzY",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "f2f22151-d6d8-4ddf-e79f-15798da2dcd2"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m9.1/9.1 MB\u001b[0m \u001b[31m69.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m6.9/6.9 MB\u001b[0m \u001b[31m111.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m1.2/1.2 MB\u001b[0m \u001b[31m16.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25h"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "2026-01-21 17:31:42.681 Thread 'MainThread': missing ScriptRunContext! This warning can be ignored when running in bare mode.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Global parameters\n",
        "\n",
        "MODEL_NAME = \"Qwen/Qwen2.5-7B-Instruct\"\n",
        "\n",
        "LOAD_PATH = \"/content/drive/My Drive/Colab Notebooks/Dissertation/JSON\"\n",
        "LOAD_GUIDELINE_STRUCTURED = os.path.join(LOAD_PATH, \"guideline_structured_normed.json\")\n",
        "LOAD_PATIENT_SCHEMA = os.path.join(LOAD_PATH, \"patient_schema.json\")\n",
        "\n",
        "SAVE_PATH = os.path.join(LOAD_PATH, \"patient_schema.json\")\n",
        "os.makedirs(SAVE_PATH, exist_ok=True)\n",
        "SAVE_FILE = os.path.join(SAVE_PATH, \"DEFINE\") # DEFINE BEFOFE RUNNING\n",
        "                                                # DEFINE BEFOFE RUNNING\n",
        "                                                # DEFINE BEFOFE RUNNING\n",
        "                                                # DEFINE BEFOFE RUNNING\n",
        "                                                # DEFINE BEFOFE RUNNING"
      ],
      "metadata": {
        "id": "aOR4djvwIaeX"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Load LLM\n",
        "\n",
        "tokenizer = AutoTokenizer.from_pretrained(MODEL_NAME)\n",
        "\n",
        "model = AutoModelForCausalLM.from_pretrained(\n",
        "    MODEL_NAME,\n",
        "    torch_dtype=\"auto\",\n",
        "    device_map=\"auto\")"
      ],
      "metadata": {
        "id": "M4JmHPGXT-Qv"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Check GPU connection\n",
        "\n",
        "import torch\n",
        "print(torch.cuda.is_available())\n",
        "print(model.device)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "7Fkzlq3RGWi9",
        "outputId": "a75865a0-12c1-43a0-f735-bc559a4f2f0e"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "True\n",
            "cuda:0\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "itw3VugfBiWy",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 422
        },
        "outputId": "6a2ab5a2-8670-4e1c-cdbd-e427afdef866"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "<class 'list'>\n",
            "116\n",
            "[{'heading_context': '1.1 Care for adults, children and young people across all phases of bipolar disorder > Treatment and support for specific populations', 'original_recommendation_number': '1.1.1', 'original_recommendation_text': 'Ensure that older people with bipolar disorder are offered the same range of treatments and services as younger people with bipolar disorder.', 'conditionality': None, 'action': ['offer the same range of treatments and services'], 'information_giving': None, 'clinical_setting': None, 'population': 'older people with bipolar disorder', 'age_group': 'older_adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.1 Care for adults, children and young people across all phases of bipolar disorder > Treatment and support for specific populations', 'original_recommendation_number': '1.1.2', 'original_recommendation_text': \"Offer people with bipolar disorder and coexisting disorders, such as personality disorder, attention deficit hyperactivity disorder, anxiety disorders or substance misuse, treatment in line with the relevant NICE guideline, in addition to their treatment for bipolar disorder. See NICE's guidelines on antisocial personality disorder , borderline personality disorder , attention deficit hyperactivity disorder , generalised anxiety disorder and panic disorder in adults and psychosis with coexisting substance misuse , be alert to the potential for drug interactions and use clinical judgement.\", 'conditionality': None, 'action': ['offer treatment'], 'information_giving': None, 'clinical_setting': None, 'population': ['people with bipolar disorder and coexisting disorders'], 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['personality disorder', 'attention deficit hyperactivity disorder', 'anxiety disorders', 'substance misuse'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.1 Care for adults, children and young people across all phases of bipolar disorder > Treatment and support for specific populations', 'original_recommendation_number': '1.1.3', 'original_recommendation_text': 'Offer people with rapid cycling bipolar disorder the same interventions as people with other types of bipolar disorder because there is currently no strong evidence to suggest that people with rapid cycling bipolar disorder should be treated differently.', 'conditionality': None, 'action': ['offer people with rapid cycling bipolar disorder the same interventions'], 'information_giving': None, 'clinical_setting': None, 'population': ['people with rapid cycling bipolar disorder'], 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.1 Care for adults, children and young people across all phases of bipolar disorder > Support for carers of people with bipolar disorder', 'original_recommendation_number': '1.1.6', 'original_recommendation_text': 'Give carers written and verbal information in an accessible format about:, and diagnosis and management of bipolar disorder, and positive outcomes and recovery, and types of support for carers, and role of teams and services, and getting help in a crisis.', 'conditionality': None, 'action': 'give carers written and verbal information in an accessible format', 'information_giving': 'null', 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Support for carers of people with bipolar disorder', 'original_recommendation_number': '1.1.7', 'original_recommendation_text': \"As early as possible negotiate with the person with bipolar disorder and their carers about how information about the person will be shared. When discussing rights to confidentiality, emphasise the importance of sharing information about risks and the need for carers to understand the person's perspective. Foster a collaborative approach that supports both people with bipolar disorder and their carers, and respects their individual needs and interdependence.\", 'conditionality': None, 'action': ['negotiate', 'discuss', 'emphasise', 'foster'], 'information_giving': [\"understand the person's perspective\"], 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.1 Care for adults, children and young people across all phases of bipolar disorder > Support for carers of people with bipolar disorder', 'original_recommendation_number': '1.1.8', 'original_recommendation_text': 'Offer a carer-focused education and support programme, which may be part of a family intervention for bipolar disorder, as early as possible to all carers. The intervention should:, and be available as needed, and have a positive message about recovery.', 'conditionality': None, 'action': ['offer a carer-focused education and support programme'], 'information_giving': None, 'clinical_setting': None, 'population': 'carers', 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Recognising and managing bipolar disorder in adults in primary care', 'original_recommendation_number': '1.2.1', 'original_recommendation_text': 'When adults present in primary care with depression , ask about previous periods of overactivity or disinhibited behaviour. If the overactivity or disinhibited behaviour lasted for 4 days or more, consider referral for a specialist mental health assessment.', 'conditionality': ['when adults present in primary care with depression'], 'action': ['consider referral for a specialist mental health assessment'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Recognising and managing bipolar disorder in adults in primary care > Recognising bipolar disorder in primary care and referral', 'original_recommendation_number': '1.2.3', 'original_recommendation_text': 'Do not use questionnaires in primary care to identify bipolar disorder in adults.', 'conditionality': None, 'action': ['do not use questionnaires'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': ['do not use questionnaires'], 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Managing bipolar disorder in primary care', 'original_recommendation_number': '1.2.4', 'original_recommendation_text': 'When working with people with bipolar disorder in primary care:, and support them to carry out care plans developed in secondary care and achieve their recovery goals, and follow crisis plans developed in secondary care and liaise with secondary care specialists if necessary, and review their treatment and care, including medication, at least annually and more often if the person, carer or healthcare professional has any concerns.', 'conditionality': None, 'action': ['support them to carry out care plans developed in secondary care', 'achieve their recovery goals', 'follow crisis plans developed in secondary care', 'liaise with secondary care specialists if necessary', 'review their treatment and care, including medication'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': 'people with bipolar disorder', 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care > Managing bipolar disorder in primary care', 'original_recommendation_number': '1.2.6', 'original_recommendation_text': 'Psychological therapists working with people with bipolar depression in primary care should have training in and experience of working with people with bipolar disorder.', 'conditionality': None, 'action': ['have training in and experience of working with people with bipolar disorder'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': 'psychological therapists', 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': True, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care > Managing bipolar disorder in primary care', 'original_recommendation_number': '1.2.7', 'original_recommendation_text': 'Do not start lithium to treat bipolar disorder in primary care for people who have not taken lithium before, except under shared-care arrangements.', 'conditionality': ['except under shared-care arrangements'], 'action': ['do not start lithium'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': 'people who have not taken lithium before', 'age_group': None, 'prohibitions_and_cautions': ['do not start lithium'], 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care > Managing bipolar disorder in primary care', 'original_recommendation_number': '1.2.8', 'original_recommendation_text': 'Do not start valproate in primary care to treat bipolar disorder.', 'conditionality': None, 'action': ['do not start valproate'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': ['do not start valproate'], 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Managing bipolar disorder in primary care', 'original_recommendation_number': '1.2.9', 'original_recommendation_text': \"If bipolar disorder is managed solely in primary care, re-refer to secondary care if any one of the following applies:, and there is a poor or partial response to treatment, and the person's functioning declines significantly, and treatment adherence is poor, and the person develops intolerable or medically important side effects from medication, and comorbid alcohol or drug misuse is suspected, and the person is considering stopping any medication after a period of relatively stable mood, and a woman with bipolar disorder is pregnant or planning a pregnancy.\", 'conditionality': ['bipolar disorder is managed solely in primary care'], 'action': ['re-refer to secondary care'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': 'people with bipolar disorder', 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': 'poor', 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'original_recommendation_number': '1.2.10', 'original_recommendation_text': 'Develop and use practice case registers to monitor the physical and mental health of people with bipolar disorder in primary care.', 'conditionality': None, 'action': ['develop and use practice case registers'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': 'people with bipolar disorder', 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'original_recommendation_number': '1.2.11', 'original_recommendation_text': 'Monitor the physical health of people with bipolar disorder when responsibility for monitoring is transferred from secondary care, and then at least annually. The health check should be comprehensive, including all the checks recommended in recommendation 1.2.12 and focusing on physical health problems such as cardiovascular disease, diabetes, obesity and respiratory disease. A copy of the results should be sent to the care coordinator and psychiatrist, and put in the secondary care records.', 'conditionality': None, 'action': ['monitor the physical health'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': 'people with bipolar disorder', 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': ['cardiovascular disease', 'diabetes', 'obesity', 'respiratory disease'], 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': 'offered'}, {'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'original_recommendation_number': '1.2.12', 'original_recommendation_text': 'Ensure that the physical health check for people with bipolar disorder, performed at least annually, includes:, and weight or BMI, diet, nutritional status and level of physical activity, and cardiovascular status, including pulse and blood pressure, and metabolic status, including fasting blood glucose or glycosylated haemoglobin (HbA1c), and blood lipid profile, and liver function, and renal and thyroid function, and calcium levels, for people taking long-term lithium.', 'conditionality': None, 'action': ['perform physical health check'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': 'people with bipolar disorder', 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': ['lithium'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'original_recommendation_number': '1.2.13', 'original_recommendation_text': \"Identify people with bipolar disorder who have hypertension, have abnormal lipid levels, are obese or at risk of obesity, have diabetes or are at risk of diabetes (as indicated by abnormal blood glucose levels), or are physically inactive, at the earliest opportunity. Follow NICE's guidelines on hypertension , cardiovascular disease: risk assessment and reduction, including lipid modification , prevention of cardiovascular disease , overweight and obesity management , physical activity and preventing type 2 diabetes .\", 'conditionality': None, 'action': ['identify people'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': 'people with bipolar disorder', 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': True, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': ['hypertension', 'diabetes'], 'physical_health_recent': ['obesity', 'abnormal lipid levels', 'physically inactive'], 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'original_recommendation_number': '1.2.14', 'original_recommendation_text': \"Offer treatment to people with bipolar disorder who have diabetes and/or cardiovascular disease in primary care in line with NICE's guidelines on type 1 diabetes in adults: diagnosis and management , type 2 diabetes in adults: management and cardiovascular disease: risk assessment and reduction, including lipid modification .\", 'conditionality': None, 'action': ['offer treatment'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': 'people with bipolar disorder', 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder', 'diabetes', 'cardiovascular disease'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': ['diabetes', 'cardiovascular disease'], 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.3 Assessing suspected bipolar disorder in adults in secondary care', 'original_recommendation_number': '1.3.1', 'original_recommendation_text': 'Assessment of suspected bipolar disorder, and subsequent management, should be conducted in a service that can:, and offer the full range of pharmacological, psychological, social, occupational and educational interventions for people with bipolar disorder consistent with this guideline, and be competent to provide all interventions offered, and place emphasis on engagement as well as risk management. This might be an early intervention in psychosis service, a specialist bipolar disorder team, or a specialist integrated community-based team.', 'conditionality': None, 'action': ['conduct assessment', 'manage'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': 'people with bipolar disorder', 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': ['pharmacological', 'psychological', 'social', 'occupational', 'educational'], 'care_coordination': None}, {'heading_context': '1.3 Assessing suspected bipolar disorder in adults in secondary care', 'original_recommendation_number': '1.3.3', 'original_recommendation_text': 'Take into account the possibility of differential diagnoses including schizophrenia spectrum disorders, personality disorders, drug misuse, alcohol-use disorders, attention deficit hyperactivity disorder and underlying physical disorders such as hypo- or hyperthyroidism.', 'conditionality': None, 'action': ['take into account'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['schizophrenia spectrum disorders', 'personality disorders', 'drug misuse', 'alcohol-use disorders', 'attention deficit hyperactivity disorder', 'underlying physical disorders such as hypo- or hyperthyroidism'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.3 Assessing suspected bipolar disorder in adults in secondary care', 'original_recommendation_number': '1.3.4', 'original_recommendation_text': 'If bipolar disorder is diagnosed, develop a care plan in collaboration with the person with bipolar disorder based on the assessment carried out in recommendation 1.3.2 as soon as possible after assessment and, depending on their needs, using the care programme approach. Give the person and their GP a copy of the plan, and encourage the person to share it with their carers .', 'conditionality': None, 'action': ['develop a care plan', 'give the person and their GP a copy of the plan', 'encourage the person to share it with their carers'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': 'people with bipolar disorder', 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.4 Managing crisis, risk and behaviour that challenges in adults with bipolar disorder in secondary care', 'original_recommendation_number': '1.4.2', 'original_recommendation_text': \"Offer crisis services to support people with bipolar disorder who are in crisis, in line with recommendations 1.4.1.1 to 1.4.1.4 in NICE's guideline on psychosis and schizophrenia in adults ., and NICE's guideline on violence and aggression: short-term management in mental health, health and community settings for advice on managing agitation, challenging behaviour and imminent violence, and on rapid tranquillisation or or, and NICE's guideline on self-harm for advice on managing acts of self‑harm and suicide risk.\", 'conditionality': None, 'action': ['offer crisis services'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': ['people with bipolar disorder'], 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.5 Managing mania or hypomania in adults in secondary care', 'original_recommendation_number': '1.5.4', 'original_recommendation_text': \"If the first antipsychotic is poorly tolerated at any dose (including rapid weight gain) or ineffective at the maximum licensed dose, offer an alternative antipsychotic from the drugs listed in recommendation 1.5.3, taking into account any advance statements, the person's preference and clinical context (including physical comorbidity, previous response to treatment and side effects).\", 'conditionality': ['if the first antipsychotic is poorly tolerated at any dose (including rapid weight gain) or ineffective at the maximum licensed dose'], 'action': ['offer an alternative antipsychotic'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.5 Managing mania or hypomania in adults in secondary care', 'original_recommendation_number': '1.5.5', 'original_recommendation_text': \"If an alternative antipsychotic is not sufficiently effective at the maximum licensed dose, consider adding lithium. Although its use is common in UK clinical practice, in September 2014 this was an off-label use of lithium. See NICE's information on prescribing medicines .\", 'conditionality': ['if an alternative antipsychotic is not sufficiently effective at the maximum licensed dose'], 'action': ['consider adding lithium'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': ['lithium'], 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.5 Managing mania or hypomania in adults in secondary care', 'original_recommendation_number': '1.5.6', 'original_recommendation_text': \"If adding lithium is ineffective, or if lithium is not suitable (for example, because the person does not agree to routine blood monitoring), consider adding valproate instead. Follow the MHRA safety measures and precautionary advice for valproate in box 1 . In September 2025 semi-sodium valproate had a UK marketing authorisation for the treatment of mania if lithium is not tolerated or is contraindicated; use of other formulations of valproate would be off-label, although use is common in UK clinical practice. See NICE's information on prescribing medicines .\", 'conditionality': ['if adding lithium is ineffective', 'if lithium is not suitable'], 'action': ['consider adding valproate instead'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['mania', 'hypomania'], 'current_medication': ['lithium'], 'medication_adherence': None, 'suggested_medication': ['valproate'], 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.5 Managing mania or hypomania in adults in secondary care', 'original_recommendation_number': '1.5.8', 'original_recommendation_text': \"If the person is already taking lithium, check plasma lithium levels to optimise treatment (see the section on how to use medication ). Consider adding haloperidol, olanzapine, quetiapine or risperidone, depending on the person's preference and previous response to treatment.\", 'conditionality': ['if the person is already taking lithium'], 'action': ['check plasma lithium levels to optimise treatment', 'consider adding haloperidol, olanzapine, quetiapine or risperidone'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['lithium'], 'medication_adherence': None, 'suggested_medication': ['haloperidol', 'olanzapine', 'quetiapine', 'risperidone'], 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.5 Managing mania or hypomania in adults in secondary care', 'original_recommendation_number': '1.5.9', 'original_recommendation_text': \"If the person is already taking a mood stabiliser as prophylactic treatment, consider increasing the dose, up to the maximum level in the BNF if necessary, depending on clinical response. If there is no improvement, consider adding haloperidol, olanzapine, quetiapine or risperidone, depending on the person's preference and previous response to treatment. Follow the recommendations on using antipsychotics in the section on how to use medication .\", 'conditionality': ['if the person is already taking a mood stabiliser as prophylactic treatment'], 'action': ['consider increasing the dose', 'consider adding haloperidol, olanzapine, quetiapine or risperidone'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['mood stabiliser'], 'medication_adherence': None, 'suggested_medication': ['haloperidol', 'olanzapine', 'quetiapine', 'risperidone'], 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.5 Managing mania or hypomania in adults in secondary care', 'original_recommendation_number': '1.5.11', 'original_recommendation_text': 'If the clinical presentation is of a mixed affective state, characterised by both manic and depressive symptoms, follow recommendations 1.5.1 to 1.5.10 for the treatment of mania, and monitor closely for the emergence of depression.', 'conditionality': ['if the clinical presentation is of a mixed affective state'], 'action': ['follow recommendations 1.5.1 to 1.5.10 for the treatment of mania', 'monitor closely for the emergence of depression'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': 'mania', 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['manic episode', 'depressive symptoms'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': None, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.5 Managing mania or hypomania in adults in secondary care', 'original_recommendation_number': '1.5.12', 'original_recommendation_text': 'Do not offer lamotrigine to treat mania.', 'conditionality': None, 'action': ['do not offer lamotrigine'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': ['do not offer lamotrigine'], 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Electroconvulsive therapy', 'original_recommendation_number': '1.5.13', 'original_recommendation_text': 'Electroconvulsive therapy (ECT) is recommended as an option in NICE technology appraisal guidance for rapid short-term treatment of a prolonged or severe manic episode when other treatments have not worked or the condition is life-threatening. For full details, see the guidance on the use of electroconvective therapy (TA59, 2009).', 'conditionality': ['when other treatments have not worked or the condition is life-threatening'], 'action': ['use electroconvulsive therapy (ECT)'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': 'none', 'current_manic_phase': 'mania', 'symptom_severity': 'severe', 'current_psychosis': 'null', 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.5 Managing mania or hypomania in adults in secondary care > Reviewing treatment for mania', 'original_recommendation_number': '1.5.14', 'original_recommendation_text': 'Within 4 weeks of resolution of symptoms, discuss with the person, and their carers if appropriate, whether to continue treatment for mania or start long‑term treatment (see the section on managing bipolar disorder in adults in the longer term in secondary care ). Explain the potential benefits of long‑term treatment and the risks, including side effects of medication used for long‑term treatment.', 'conditionality': None, 'action': ['discuss with the person', 'start long-term treatment'], 'information_giving': ['explain the potential benefits of long-term treatment', 'explain the risks, including side effects of medication used for long-term treatment'], 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': 'mania', 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.5 Managing mania or hypomania in adults in secondary care', 'original_recommendation_number': '1.5.15', 'original_recommendation_text': 'If the person decides to continue treatment for mania, offer it for a further 3 to 6 months, and then review.', 'conditionality': ['if the person decides to continue treatment for mania'], 'action': ['offer it for a further 3 to 6 months, and then review'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': 'mania', 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.6 Managing bipolar depression in adults in secondary care', 'original_recommendation_number': '1.6.1', 'original_recommendation_text': 'Offer adults with bipolar depression:, and a psychological intervention that has been developed specifically for bipolar disorder and has a published evidence-based manual describing how it should be delivered or or, and a choice of psychological intervention (cognitive behavioural therapy, interpersonal therapy or behavioural couples therapy) in line with the advice on treatment options for more severe depression in the NICE guideline on depression . Discuss with the person the possible benefits and risks of psychological interventions and their preference. Monitor mood for signs of mania or hypomania or deterioration of the depressive symptoms.', 'conditionality': None, 'action': ['offer a psychological intervention', 'choose a psychological intervention from cognitive behavioural therapy, interpersonal therapy or behavioural couples therapy', 'monitor mood'], 'information_giving': ['discuss with the person the possible benefits and risks of psychological interventions and their preference'], 'clinical_setting': 'secondary_care', 'population': 'adults with bipolar depression', 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': True, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.6 Managing bipolar depression in adults in secondary care', 'original_recommendation_number': '1.6.2', 'original_recommendation_text': 'Psychological therapists working with people with bipolar depression should have training in, and experience of, working with people with bipolar disorder.', 'conditionality': None, 'action': ['have training in', 'experience of'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': 'people with bipolar depression', 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': True, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.6 Managing bipolar depression in adults in secondary care', 'original_recommendation_number': '1.6.5', 'original_recommendation_text': 'If a person develops moderate or severe bipolar depression and is already taking valproate , review their treatment including adherence and consider increasing the dose if tolerated but be aware of the increased risk of side effects at higher doses. Follow the recommendations on using valproate in the section on how to use medication .', 'conditionality': ['if a person develops moderate or severe bipolar depression and is already taking valproate'], 'action': ['review their treatment', 'consider increasing the dose if tolerated'], 'information_giving': ['be aware of the increased risk of side effects at higher doses'], 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': 'moderate, severe', 'current_psychosis': None, 'diagnoses': ['bipolar depression'], 'current_medication': ['valproate'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.6 Managing bipolar depression in adults in secondary care', 'original_recommendation_number': '1.6.6', 'original_recommendation_text': \"If the maximum tolerated dose, or the top of the therapeutic range for valproate, has been reached and there is a limited response, add either of the following options, depending on the person's preference and previous response to treatment:, and fluoxetine combined with olanzapine or or, and quetiapine. Follow the recommendations on using valproate and antipsychotics in the section on how to use medication . In September 2014, these were off-label uses of olanzapine, quetiapine and valproate for children and young people. See NICE's information on prescribing medicines .\", 'conditionality': ['if the maximum tolerated dose, or the top of the therapeutic range for valproate, has been reached and there is a limited response'], 'action': ['add either of the following options', 'follow the recommendations on using valproate and antipsychotics in the section on how to use medication'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar depression'], 'current_medication': ['valproate'], 'medication_adherence': None, 'suggested_medication': ['fluoxetine combined with olanzapine', 'quetiapine'], 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.6 Managing bipolar depression in adults in secondary care', 'original_recommendation_number': '1.6.7', 'original_recommendation_text': \"If the person does not wish to try adding fluoxetine combined with olanzapine or adding quetiapine, consider:, and adding olanzapine (without fluoxetine) or or, and adding lamotrigine or or, and changing from valproate to an alternative treatment. Follow the recommendations on using valproate, antipsychotics and lamotrigine in the section on how to use medication . In September 2014, these were off-label uses of olanzapine, quetiapine, lamotrigine and valproate for children and young people. See NICE's information on prescribing medicines .\", 'conditionality': ['if the person does not wish to try adding fluoxetine combined with olanzapine or adding quetiapine'], 'action': ['consider adding olanzapine (without fluoxetine)', 'consider adding lamotrigine', 'consider changing from valproate to an alternative treatment'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar depression'], 'current_medication': ['valproate'], 'medication_adherence': None, 'suggested_medication': ['olanzapine', 'lamotrigine'], 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.6 Managing bipolar depression in adults in secondary care', 'original_recommendation_number': '1.6.8', 'original_recommendation_text': \"If there is no response to adding fluoxetine combined with olanzapine or adding quetiapine, consider stopping the additional medications and:, and adding lamotrigine to valproate or, and changing from valproate to an alternative treatment. Follow the recommendations on using valproate, antipsychotics and lamotrigine in the section on how to use medication . In September 2014, these were off-label uses of olanzapine, quetiapine, lamotrigine and valproate for children and young people. See NICE's information on prescribing medicines .\", 'conditionality': ['if there is no response'], 'action': ['consider stopping the additional medications', 'adding lamotrigine to valproate', 'changing from valproate to an alternative treatment'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar depression'], 'current_medication': ['fluoxetine combined with olanzapine', 'quetiapine', 'valproate'], 'medication_adherence': None, 'suggested_medication': ['lamotrigine', 'alternative treatment'], 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.6 Managing bipolar depression in adults in secondary care', 'original_recommendation_number': '1.6.9', 'original_recommendation_text': 'Follow the recommendations on using antipsychotics in the section on how to use medication and be aware of the potential interactions between valproate and fluoxetine, lamotrigine and olanzapine. Follow the MHRA safety measures and precautionary advice for valproate in box 1 . [2014, amended 2020] [2014, amended 2020]', 'conditionality': None, 'action': ['follow the recommendations', 'be aware'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar depression'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': ['antipsychotics', 'valproate', 'fluoxetine', 'lamotrigine', 'olanzapine'], 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.6 Managing bipolar depression in adults in secondary care', 'original_recommendation_number': '1.6.10', 'original_recommendation_text': 'Take into account toxicity in overdose when prescribing psychotropic medication during periods of high suicide risk. Assess the need to limit the quantity of medication supplied to reduce the risk to life if the person overdoses.', 'conditionality': None, 'action': ['take into account toxicity in overdose', 'assess the need to limit the quantity of medication supplied'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar depression'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': 'self_harm', 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.6 Managing bipolar depression in adults in secondary care > Reviewing treatment for bipolar depression', 'original_recommendation_number': '1.6.11', 'original_recommendation_text': 'Within 4 weeks of resolution of symptoms, discuss with the person, and their carers if appropriate, whether to continue psychological or pharmacological treatment for bipolar depression or start long-term treatment (see the section on managing bipolar disorder in adults in the longer term in secondary care ). Explain the potential benefits of long-term treatment and the risks, including side effects of medication used for long-term treatment.', 'conditionality': None, 'action': ['discuss with the person', 'start long-term treatment'], 'information_giving': ['explain the potential benefits of long-term treatment and the risks, including side effects of medication used for long-term treatment'], 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar depression'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.6 Managing bipolar depression in adults in secondary care', 'original_recommendation_number': '1.6.12', 'original_recommendation_text': 'If the person decides to continue psychological or pharmacological treatment for bipolar depression, offer it for a further 3 to 6 months, and then review.', 'conditionality': ['if the person decides to continue'], 'action': ['offer it for a further 3 to 6 months', 'review'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar depression'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': True, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'original_recommendation_number': '1.7.2', 'original_recommendation_text': \"Offer a family intervention to people with bipolar disorder who are living, or in close contact, with their family in line with recommendation 1.3.7.2 in NICE's guideline on psychosis and schizophrenia in adults .\", 'conditionality': None, 'action': ['offer a family intervention'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': ['people with bipolar disorder'], 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'original_recommendation_number': '1.7.3', 'original_recommendation_text': 'Offer a structured psychological intervention (individual, group or family), which has been designed for bipolar disorder and has a published evidence-based manual describing how it should be delivered, to prevent relapse or for people who have some persisting symptoms between episodes of mania or bipolar depression.', 'conditionality': None, 'action': ['offer a structured psychological intervention'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': True, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'original_recommendation_number': '1.7.5', 'original_recommendation_text': 'When planning long-term pharmacological treatment to prevent relapse, take into account drugs that have been effective during episodes of mania or bipolar depression. Discuss with the person whether they prefer to continue this treatment or switch to lithium, and explain that lithium is the most effective long-term treatment for bipolar disorder.', 'conditionality': None, 'action': ['take into account drugs', 'discuss with the person', 'explain that lithium is the most effective long-term treatment'], 'information_giving': ['explain that lithium is the most effective long-term treatment'], 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': 'one', 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': ['lithium'], 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'original_recommendation_number': '1.7.6', 'original_recommendation_text': 'When considering long-term treatment, discuss with the person the possible benefits and risks of each drug for them, following the recommendations in the section on how to use medication .', 'conditionality': None, 'action': ['discuss with the person'], 'information_giving': ['the possible benefits and risks of each drug for them'], 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'original_recommendation_number': '1.7.7', 'original_recommendation_text': 'Offer lithium as a first-line, long-term pharmacological treatment for bipolar disorder.', 'conditionality': None, 'action': ['offer lithium'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': ['lithium'], 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'original_recommendation_number': '1.7.8', 'original_recommendation_text': 'If lithium is ineffective, poorly tolerated, or is not suitable (for example, because the person does not agree to routine blood monitoring), consider an antipsychotic (for example, asenapine, aripiprazole, olanzapine, quetiapine or risperidone).', 'conditionality': ['if lithium is ineffective, poorly tolerated, or is not suitable'], 'action': ['consider an antipsychotic'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': ['lithium'], 'medication_adherence': None, 'suggested_medication': ['asenapine', 'aripiprazole', 'olanzapine', 'quetiapine', 'risperidone'], 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'original_recommendation_number': '1.7.9', 'original_recommendation_text': 'If the first antipsychotic is poorly tolerated at any dose (including rapid weight gain) or ineffective at the maximum licensed dose, consider an alternative antipsychotic from the drugs listed in recommendation 1.7.8.', 'conditionality': ['if the first antipsychotic is poorly tolerated at any dose (including rapid weight gain) or ineffective at the maximum licensed dose'], 'action': ['consider an alternative antipsychotic'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': ['antipsychotic'], 'medication_adherence': None, 'suggested_medication': ['alternative antipsychotic'], 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'original_recommendation_number': '1.7.10', 'original_recommendation_text': \"If an alternative antipsychotic is ineffective, consider a combination of valproate (follow the MHRA safety measures and precautionary advice for valproate in box 1 ), with either:, and an antipsychotic or, and lithium. In September 2025 semi-sodium valproate had a UK marketing authorisation for this indication in people who have had mania that has responded to treatment with semi-sodium valproate; use of other formulations of valproate would be off-label, although use is common in UK clinical practice. See NICE's information on prescribing medicines .\", 'conditionality': ['if an alternative antipsychotic is ineffective'], 'action': ['consider a combination of valproate with either an antipsychotic or lithium'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': ['follow the MHRA safety measures and precautionary advice for valproate in box 1'], 'urgency': False, 'manic_episode_history': 'none', 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': ['valproate'], 'medication_adherence': None, 'suggested_medication': ['valproate combined with an antipsychotic', 'valproate combined with lithium'], 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'original_recommendation_number': '1.7.11', 'original_recommendation_text': 'If stopping long-term pharmacological treatment:, and discuss with the person how to recognise early signs of relapse and what to do if symptoms recur, and stop treatment gradually (see the section on how to use medication ) and monitor the person for signs of relapse.', 'conditionality': ['if stopping long-term pharmacological treatment'], 'action': ['stop treatment gradually', 'monitor the person for signs of relapse'], 'information_giving': ['discuss with the person how to recognise early signs of relapse and what to do if symptoms recur'], 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'original_recommendation_number': '1.7.12', 'original_recommendation_text': 'Continue monitoring symptoms, mood and mental state for 2 years after medication has stopped entirely. This may be undertaken in primary care (see recommendation 1.9.3 ).', 'conditionality': None, 'action': ['continue monitoring symptoms', 'monitor mood', 'monitor mental state'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.8 Monitoring physical health in secondary care', 'original_recommendation_number': '1.8.1', 'original_recommendation_text': 'Healthcare professionals in secondary care should ensure, as part of the care programme approach, that people with bipolar disorder receive physical healthcare from primary care as described in recommendations 1.2.10 to 1.2.14 after responsibility for monitoring has been transferred from secondary care.', 'conditionality': None, 'action': ['ensure'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': 'people with bipolar disorder', 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': 'offered'}, {'heading_context': '1.8 Monitoring physical health in secondary care', 'original_recommendation_number': '1.8.2', 'original_recommendation_text': 'People with bipolar disorder, especially those taking antipsychotics and long-term medication, should be offered a combined healthy eating and physical activity programme by their mental healthcare provider.', 'conditionality': ['especially those taking antipsychotics and long-term medication'], 'action': ['offer a combined healthy eating and physical activity programme'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': ['people with bipolar disorder'], 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': ['antipsychotics', 'long-term medication'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': ['healthy eating and physical activity programme'], 'care_coordination': None}, {'heading_context': '1.8 Monitoring physical health in secondary care', 'original_recommendation_number': '1.8.3', 'original_recommendation_text': 'If a person has rapid or excessive weight gain, abnormal lipid levels or problems with blood glucose management, take into account the effects of medication, mental state, other physical health and lifestyle factors in the development of these problems.', 'conditionality': ['if a person has rapid or excessive weight gain, abnormal lipid levels or problems with blood glucose management'], 'action': ['take into account the effects of medication, mental state, other physical health and lifestyle factors'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.8 Monitoring physical health in secondary care', 'original_recommendation_number': '1.8.4', 'original_recommendation_text': 'Routinely monitor weight and cardiovascular and metabolic indicators of morbidity in people with bipolar disorder. These should be audited in the annual team report.', 'conditionality': None, 'action': ['monitor weight', 'monitor cardiovascular indicators', 'monitor metabolic indicators'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': 'people with bipolar disorder', 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.8 Monitoring physical health in secondary care', 'original_recommendation_number': '1.8.5', 'original_recommendation_text': 'Trusts should ensure that they take account of relevant guidelines on the monitoring and treatment of cardiovascular and metabolic disease in people with bipolar disorder through board-level performance indicators.', 'conditionality': None, 'action': ['take account of relevant guidelines'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': ['cardiovascular disease', 'metabolic disease'], 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.9 Promoting recovery and return to primary care > Continuing treatment in secondary care', 'original_recommendation_number': '1.9.1', 'original_recommendation_text': 'Continue treatment and care in an early intervention in psychosis service, a specialist bipolar disorder service or a specialist integrated community-based team. Share physical health monitoring with primary care as outlined in the sections on physical health and monitoring physical health in primary care .', 'conditionality': None, 'action': ['continue treatment and care'], 'information_giving': ['share physical health monitoring with primary care'], 'clinical_setting': 'secondary_care', 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['early intervention in psychosis', 'bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.9 Promoting recovery and return to primary care > Continuing treatment in secondary care', 'original_recommendation_number': '1.9.2', 'original_recommendation_text': 'Consider intensive case management for people with bipolar disorder who are likely to disengage from treatment or services.', 'conditionality': ['who are likely to disengage from treatment or services'], 'action': ['consider intensive case management'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': 'people with bipolar disorder', 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.9 Promoting recovery and return to primary care > Return to primary care', 'original_recommendation_number': '1.9.3', 'original_recommendation_text': 'Offer people with bipolar disorder whose symptoms have responded effectively to treatment and remain stable the option to return to primary care for further management. If they wish to do this, record it in their notes and coordinate transfer of responsibilities through the care programme approach.', 'conditionality': ['if they wish to do this'], 'action': ['offer people with bipolar disorder the option to return to primary care'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': 'people with bipolar disorder', 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': 'coordinate transfer of responsibilities through the care programme approach'}, {'heading_context': '1.9 Promoting recovery and return to primary care > Return to primary care', 'original_recommendation_number': '1.9.4', 'original_recommendation_text': \"When making transfer arrangements for a return to primary care, agree a care plan with the person, which includes:, and clear, individualised social and emotional recovery goals, and a crisis plan indicating early warning symptoms and triggers of both mania and depression relapse and preferred response during relapse, including liaison and referral pathways, and an assessment of the person's mental state, and a medication plan with a date for review by primary care, frequency and nature of monitoring for effectiveness and adverse effects, and what should happen in the event of a relapse. Give the person and their GP a copy of the plan, and encourage the person to share it with their carers .\", 'conditionality': None, 'action': ['agree a care plan with the person', 'give the person and their GP a copy of the plan', 'encourage the person to share it with their carers'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.9 Promoting recovery and return to primary care > Return to primary care', 'original_recommendation_number': '1.9.5', 'original_recommendation_text': 'Encourage and support the person to visit their GP and discuss the care plan before discharge and transfer.', 'conditionality': None, 'action': ['encourage and support the person to visit their GP and discuss the care plan'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication', 'original_recommendation_number': '1.10.1', 'original_recommendation_text': \"When using any psychotropic medication for bipolar disorder ensure that:, and the person is given information that is suitable for their developmental level about the purpose and likely side effects of treatment including any monitoring that is required, and give them an opportunity to ask questions, and the choice of medication is made in collaboration with the person with bipolar disorder, taking into account the carer's views if the person agrees, and the overall medication regimen is regularly reviewed so that drugs that are not needed after the acute episode are stopped.\", 'conditionality': None, 'action': ['give them an opportunity to ask questions', 'make the choice of medication in collaboration with the person with bipolar disorder', 'review the overall medication regimen'], 'information_giving': ['give information that is suitable for their developmental level about the purpose and likely side effects of treatment including any monitoring that is required'], 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication', 'original_recommendation_number': '1.10.2', 'original_recommendation_text': 'Discuss the use of alcohol, tobacco, prescription and non-prescription medication and illicit drugs with the person, and their carer if appropriate. Explain the possible interference of these substances with the therapeutic effects of prescribed medication and psychological interventions.', 'conditionality': None, 'action': ['discuss', 'explain'], 'information_giving': ['explain'], 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication', 'original_recommendation_number': '1.10.3', 'original_recommendation_text': 'When offering psychotropic medication to older people , take into account its impact on cognitive functioning in older people and:, and use medication at lower doses, and take into account the increased risk of drug interactions, and take into account the negative impact that anticholinergic medication, or drugs with anticholinergic activity, can have on cognitive function and mobility, and ensure that medical comorbidities have been recognised and treated.', 'conditionality': ['when offering psychotropic medication to older people'], 'action': ['use medication at lower doses', 'take into account the increased risk of drug interactions', 'take into account the negative impact that anticholinergic medication, or drugs with anticholinergic activity, can have on cognitive function and mobility', 'ensure that medical comorbidities have been recognised and treated'], 'information_giving': None, 'clinical_setting': None, 'population': 'older_adult', 'age_group': 'older_adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication', 'original_recommendation_number': '1.10.4', 'original_recommendation_text': 'Do not offer gabapentin or topiramate to treat bipolar disorder.', 'conditionality': None, 'action': None, 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': ['do not offer gabapentin or topiramate'], 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using antipsychotic medication > Starting antipsychotic medication', 'original_recommendation_number': '1.10.5', 'original_recommendation_text': \"Before starting antipsychotic medication, measure and record the person's:, and weight or BMI, and pulse, and blood pressure, and fasting blood glucose or HbA1c, and blood lipid profile.\", 'conditionality': None, 'action': [\"measure and record the person's weight or BMI\", \"measure and record the person's pulse\", \"measure and record the person's blood pressure\", \"measure and record the person's fasting blood glucose or HbA1c\", \"measure and record the person's blood lipid profile\"], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using antipsychotic medication > Starting antipsychotic medication', 'original_recommendation_number': '1.10.6', 'original_recommendation_text': \"Before starting antipsychotic medication, offer the person an electrocardiogram (ECG) if:, and it is specified in the drug's summary of product characteristics (SPC) or or, and a physical examination has identified a specific cardiovascular risk (such as hypertension) or or, and there is a family history of cardiovascular disease, a history of sudden collapse, or other cardiovascular risk factors such as cardiac arrhythmia or or, and the person is being admitted as an inpatient.\", 'conditionality': [\"it is specified in the drug's summary of product characteristics (SPC)\", 'a physical examination has identified a specific cardiovascular risk (such as hypertension)', 'there is a family history of cardiovascular disease', 'a history of sudden collapse', 'other cardiovascular risk factors such as cardiac arrhythmia', 'the person is being admitted as an inpatient'], 'action': 'offer the person an electrocardiogram (ECG)', 'information_giving': None, 'clinical_setting': 'inpatient', 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using antipsychotic medication > Monitoring antipsychotic medication', 'original_recommendation_number': '1.10.8', 'original_recommendation_text': 'Monitor and record the following during dose titration and then regularly and systematically throughout treatment:, and pulse and blood pressure after each dose change, and weight or BMI weekly for the first 6 weeks, then at 12 weeks, and fasting blood glucose or HbA1c, and blood lipid profile at 12 weeks, and response to treatment, including changes in symptoms and behaviour, and side effects and their impact on physical health and functioning, and the emergence of movement disorders, and adherence.', 'conditionality': None, 'action': ['monitor and record'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using antipsychotic medication > Monitoring antipsychotic medication', 'original_recommendation_number': '1.10.9', 'original_recommendation_text': \"The secondary care team should maintain responsibility for monitoring the efficacy and tolerability of antipsychotic medication for at least the first 12 months or until the person's condition has stabilised, whichever is longer. Thereafter, the responsibility for this monitoring may be transferred to primary care under shared-care arrangements.\", 'conditionality': None, 'action': ['monitor the efficacy and tolerability of antipsychotic medication'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['antipsychotic medication'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': 'offered'}, {'heading_context': '1.10 How to use medication > Using antipsychotic medication > Monitoring antipsychotic medication', 'original_recommendation_number': '1.10.10', 'original_recommendation_text': 'If out-of-range test results are reported at any stage of treatment, the healthcare professional who ordered the tests should ensure that the person is offered further investigations and treatment as needed.', 'conditionality': ['if out-of-range test results are reported'], 'action': ['ensure that the person is offered further investigations and treatment as needed'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using antipsychotic medication > Monitoring antipsychotic medication', 'original_recommendation_number': '1.10.11', 'original_recommendation_text': \"'As required' (p.r.n.) prescriptions of antipsychotic medication should be made as described in recommendation 1.10.7. Review clinical indications, frequency of administration, therapeutic benefits and side effects each week or more often if needed. Ensure that p.r.n. prescriptions have not unintentionally led to a total antipsychotic dosage above the maximum specified in the BNF or SPC.\", 'conditionality': ['as required'], 'action': ['review clinical indications', 'review frequency of administration', 'review therapeutic benefits', 'review side effects', 'ensure that p.r.n. prescriptions have not unintentionally led to a total antipsychotic dosage above the maximum specified in the BNF or SPC'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['antipsychotic medication'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using antipsychotic medication > Monitoring antipsychotic medication', 'original_recommendation_number': '1.10.12', 'original_recommendation_text': 'Do not start regular combined antipsychotic medication, except for short periods (for example, when changing medication).', 'conditionality': None, 'action': ['do not start regular combined antipsychotic medication'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': ['do not start regular combined antipsychotic medication'], 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using antipsychotic medication > Stopping antipsychotic drugs', 'original_recommendation_number': '1.10.13', 'original_recommendation_text': 'If stopping an antipsychotic drug, reduce the dose gradually over at least 4 weeks to minimise the risk of relapse.', 'conditionality': ['if stopping an antipsychotic drug'], 'action': ['reduce the dose gradually over at least 4 weeks'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['antipsychotic drug'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lithium > Starting lithium', 'original_recommendation_number': '1.10.14', 'original_recommendation_text': \"When starting lithium:, and advise the person that poor adherence or rapid discontinuation may increase the risk of relapse, and measure the person's weight or BMI and arrange tests for urea and electrolytes including calcium, estimated glomerular filtration rate (eGFR), thyroid function and a full blood count, and arrange an ECG for people with cardiovascular disease or risk factors for it, and ensure the person is given appropriate national information (or a locally available equivalent) on taking lithium safely, and establish a shared‑care arrangement with the person's GP for prescribing lithium and monitoring adverse effects.\", 'conditionality': None, 'action': [\"measure the person's weight or BMI\", 'arrange tests for urea and electrolytes including calcium, estimated glomerular filtration rate (eGFR), thyroid function and a full blood count', 'arrange an ECG for people with cardiovascular disease or risk factors for it', 'ensure the person is given appropriate national information (or a locally available equivalent) on taking lithium safely', \"establish a shared-care arrangement with the person's GP for prescribing lithium and monitoring adverse effects\"], 'information_giving': ['advise the person that poor adherence or rapid discontinuation may increase the risk of relapse'], 'clinical_setting': 'primary_care', 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': \"established a shared-care arrangement with the person's GP\"}, {'heading_context': '1.10 How to use medication > Using lithium > Starting lithium', 'original_recommendation_number': '1.10.15', 'original_recommendation_text': 'Measure plasma lithium levels 1 week after starting lithium and 1 week after every dose change, and weekly until the levels are stable. Aim to maintain plasma lithium level between 0.6 and 0.8 mmol per litre in people being prescribed lithium for the first time.', 'conditionality': None, 'action': ['measure plasma lithium levels', 'maintain plasma lithium level'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['lithium'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lithium > Starting lithium', 'original_recommendation_number': '1.10.16', 'original_recommendation_text': 'Consider maintaining plasma lithium levels at 0.8 to 1.0 mmol per litre for a trial period of at least 6 months for people who:, and have had a relapse while taking lithium in the past or or, and are taking lithium and have subthreshold symptoms with functional impairment.', 'conditionality': ['have had a relapse while taking lithium in the past', 'are taking lithium and have subthreshold symptoms with functional impairment'], 'action': ['maintain plasma lithium levels'], 'information_giving': None, 'clinical_setting': None, 'population': 'people who have had a relapse while taking lithium in the past or are taking lithium and have subthreshold symptoms with functional impairment', 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['lithium'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lithium > Starting lithium', 'original_recommendation_number': '1.10.17', 'original_recommendation_text': 'Advise people taking lithium to:, and seek medical attention if they develop diarrhoea or vomiting or become acutely ill for any reason, and ensure they maintain their fluid intake, particularly after sweating (for example, after exercise, in hot climates or if they have a fever), if they are immobile for long periods or if they develop a chest infection or pneumonia, and talk to their doctor as soon as possible if they become pregnant or are planning a pregnancy.', 'conditionality': None, 'action': ['advise', 'seek medical attention', 'ensure they maintain their fluid intake', 'talk to their doctor'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': 'people taking lithium', 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['lithium'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': None, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lithium > Starting lithium', 'original_recommendation_number': '1.10.18', 'original_recommendation_text': 'Warn people taking lithium not to take over-the-counter non-steroidal anti-inflammatory drugs and avoid prescribing these drugs for people with bipolar disorder if possible; if they are prescribed, this should be on a regular (not when required) basis and the person should be monitored monthly until a stable lithium level is reached and then every 3 months.', 'conditionality': ['if they are prescribed'], 'action': ['monitor the person monthly', 'monitor the person every 3 months'], 'information_giving': ['warn people taking lithium'], 'clinical_setting': None, 'population': ['people with bipolar disorder'], 'age_group': None, 'prohibitions_and_cautions': ['do not take over-the-counter non-steroidal anti-inflammatory drugs', 'avoid prescribing these drugs if possible', 'prescribe these drugs on a regular basis, not when required'], 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': ['lithium'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lithium > Monitoring lithium', 'original_recommendation_number': '1.10.19', 'original_recommendation_text': \"Measure the person's plasma lithium level every 3 months for the first year.\", 'conditionality': None, 'action': [\"measure the person's plasma lithium level\"], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lithium > Monitoring lithium', 'original_recommendation_number': '1.10.20', 'original_recommendation_text': 'After the first year, measure plasma lithium levels every 6 months, or every 3 months for people in any of the following groups:, and older people, and people taking drugs that interact with lithium, and people who are at risk of impaired renal or thyroid function, raised calcium levels or other complications, and people who have poor symptom control, and people with poor adherence, and people whose last plasma lithium level was 0.8 mmol per litre or higher.', 'conditionality': ['people in any of the following groups:'], 'action': ['measure plasma lithium levels'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': 'older_adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': 'poor', 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lithium > Monitoring lithium', 'original_recommendation_number': '1.10.21', 'original_recommendation_text': \"Measure the person's weight or BMI and arrange tests for urea and electrolytes including calcium, estimated glomerular filtration rate (eGFR) and thyroid function every 6 months, and more often if there is evidence of impaired renal or thyroid function, raised calcium levels or an increase in mood symptoms that might be related to impaired thyroid function.\", 'conditionality': ['if there is evidence of impaired renal or thyroid function, raised calcium levels or an increase in mood symptoms that might be related to impaired thyroid function'], 'action': [\"measure the person's weight or BMI\", 'arrange tests for urea and electrolytes including calcium, estimated glomerular filtration rate (eGFR) and thyroid function'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lithium > Monitoring lithium', 'original_recommendation_number': '1.10.22', 'original_recommendation_text': \"Monitor lithium dose and plasma lithium levels more frequently if urea levels and creatinine levels become elevated, or eGFR falls over 2 or more tests, and assess the rate of deterioration of renal function. For further information see NICE's guidelines on chronic kidney disease and acute kidney injury .\", 'conditionality': ['if urea levels and creatinine levels become elevated', 'if eGFR falls over 2 or more tests'], 'action': ['monitor lithium dose and plasma lithium levels more frequently', 'assess the rate of deterioration of renal function'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['lithium'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': ['chronic kidney disease', 'acute kidney injury'], 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lithium > Monitoring lithium', 'original_recommendation_number': '1.10.23', 'original_recommendation_text': 'When discussing whether to continue lithium, take into account clinical efficacy, other risk factors for renal impairment and cardiovascular disease, and degree of renal impairment; if needed seek advice from a renal specialist and a clinician with expertise in managing bipolar disorder.', 'conditionality': ['when discussing whether to continue lithium'], 'action': ['take into account clinical efficacy', 'take into account other risk factors for renal impairment and cardiovascular disease', 'take into account degree of renal impairment', 'seek advice from a renal specialist', 'seek advice from a clinician with expertise in managing bipolar disorder'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': ['lithium'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lithium > Monitoring lithium', 'original_recommendation_number': '1.10.24', 'original_recommendation_text': 'Monitor the person at every appointment for symptoms of neurotoxicity, including paraesthesia, ataxia, tremor and cognitive impairment, which can occur at therapeutic levels of lithium.', 'conditionality': None, 'action': ['monitor the person'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['lithium'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lithium > Stopping lithium', 'original_recommendation_number': '1.10.25', 'original_recommendation_text': 'If stopping lithium, reduce the dose gradually over at least 4 weeks, and preferably up to 3 months, even if the person has started taking another antimanic drug.', 'conditionality': ['if stopping lithium'], 'action': ['reduce the dose gradually over at least 4 weeks, and preferably up to 3 months'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['lithium'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lithium > Stopping lithium', 'original_recommendation_number': '1.10.26', 'original_recommendation_text': 'During dose reduction and for 3 months after lithium treatment is stopped, monitor the person closely for early signs of mania and depression.', 'conditionality': None, 'action': ['monitor the person closely'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['lithium'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using valproate', 'original_recommendation_number': '1.10.27', 'original_recommendation_text': 'If a woman or girl of childbearing potential is already taking valproate, advise her to gradually stop the drug under medical supervision because of the risk of fetal malformations and adverse neurodevelopmental outcomes after any exposure in pregnancy . Follow the MHRA safety measures and precautionary advice for valproate in box 1 . [2014, amended 2020] [2014, amended 2020]', 'conditionality': ['a woman or girl of childbearing potential is already taking valproate'], 'action': ['advise her to gradually stop the drug under medical supervision'], 'information_giving': None, 'clinical_setting': None, 'population': ['woman or girl of childbearing potential'], 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['valproate'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication', 'original_recommendation_number': '1.10.28', 'original_recommendation_text': 'Be aware that there is a possible association between valproate use in men around the time of conception and an increased risk of neurodevelopmental disorders in their children. Follow the MHRA safety measures and precautionary advice for valproate in box 1 . [2025] [2025]', 'conditionality': None, 'action': None, 'information_giving': ['follow the MHRA safety measures and precautionary advice for valproate'], 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using valproate > Starting valproate', 'original_recommendation_number': '1.10.29', 'original_recommendation_text': \"When starting valproate, measure the person's weight or BMI and carry out a full blood count and liver function tests.\", 'conditionality': None, 'action': [\"measure the person's weight or BMI\", 'carry out a full blood count and liver function tests'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using valproate > Starting valproate', 'original_recommendation_number': '1.10.30', 'original_recommendation_text': 'Advise people taking valproate, and their carers, how to recognise the signs and symptoms of blood and liver disorders and to seek immediate medical help if any of these develop. Stop valproate immediately if abnormal liver function or blood dyscrasia is detected. Although the absolute values of hepatic enzymes are a poor indicator of the extent of hepatic damage, it is generally accepted that if these are persistently elevated to over 3 times the upper normal limit, continuing to rise or accompanied by clinical symptoms, the suspected drug should be withdrawn. Raised hepatic enzymes of any magnitude accompanied by reduced albumin or impaired clotting suggest severe liver disease.', 'conditionality': None, 'action': ['advise people taking valproate, and their carers, how to recognise the signs and symptoms of blood and liver disorders', 'stop valproate immediately if abnormal liver function or blood dyscrasia is detected'], 'information_giving': ['seek immediate medical help if any of these develop'], 'clinical_setting': None, 'population': ['people taking valproate', 'their carers'], 'age_group': None, 'prohibitions_and_cautions': ['stop valproate immediately if abnormal liver function or blood dyscrasia is detected'], 'urgency': True, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['valproate'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using valproate > Starting valproate', 'original_recommendation_number': '1.10.31', 'original_recommendation_text': 'When prescribing valproate, be aware of its interactions with other anticonvulsants (particularly carbamazepine and lamotrigine) and with olanzapine and smoking.', 'conditionality': None, 'action': ['be aware'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using valproate > Monitoring valproate', 'original_recommendation_number': '1.10.32', 'original_recommendation_text': 'Do not routinely measure plasma valproate levels unless there is evidence of ineffectiveness, poor adherence or toxicity.', 'conditionality': None, 'action': ['do not routinely measure plasma valproate levels'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': ['do not routinely measure plasma valproate levels unless there is evidence of ineffectiveness, poor adherence or toxicity'], 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using valproate', 'original_recommendation_number': '1.10.33', 'original_recommendation_text': \"Measure the person's weight or BMI and carry out liver function tests and a full blood count again after 6 months of treatment with valproate and repeat annually.\", 'conditionality': None, 'action': [\"measure the person's weight or BMI\", 'carry out liver function tests', 'carry out a full blood count'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['valproate'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using valproate > Monitoring valproate', 'original_recommendation_number': '1.10.34', 'original_recommendation_text': 'Monitor sedation, tremor and gait disturbance carefully in older people.', 'conditionality': None, 'action': ['monitor sedation', 'monitor tremor', 'monitor gait disturbance'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': 'older_adult', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using valproate > Stopping valproate', 'original_recommendation_number': '1.10.35', 'original_recommendation_text': 'If stopping valproate, to change to an alternative medication, reduce the dose gradually over at least 4 weeks to minimise the risk of relapse.', 'conditionality': ['if stopping valproate'], 'action': ['reduce the dose gradually over at least 4 weeks'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['valproate'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lamotrigine > Starting lamotrigine', 'original_recommendation_number': '1.10.36', 'original_recommendation_text': 'When starting lamotrigine:, and carry out a full blood count, urea and electrolytes and liver function tests, and be aware of its interaction with valproate, and follow the instructions for initial dosage and dosage titration outlined in the SPC and BNF , taking into account the need for slow titration in people who have not taken lamotrigine before.', 'conditionality': ['when starting lamotrigine'], 'action': ['carry out a full blood count', 'carry out urea and electrolytes', 'carry out liver function tests', 'be aware of its interaction with valproate', 'follow the instructions for initial dosage and dosage titration'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': ['lamotrigine'], 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lamotrigine > Starting lamotrigine', 'original_recommendation_number': '1.10.37', 'original_recommendation_text': 'Advise people taking lamotrigine to:, and contact their doctor immediately if they develop a rash while the dose of lamotrigine is being increased, and tell you if they are pregnant or planning a pregnancy.', 'conditionality': None, 'action': ['contact their doctor immediately', 'tell you if they are pregnant or planning a pregnancy'], 'information_giving': ['advise people taking lamotrigine to'], 'clinical_setting': None, 'population': 'people taking lamotrigine', 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': True, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['lamotrigine'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lamotrigine > Monitoring lamotrigine', 'original_recommendation_number': '1.10.38', 'original_recommendation_text': 'Do not routinely measure plasma lamotrigine levels unless there is evidence of ineffectiveness, poor adherence or toxicity.', 'conditionality': None, 'action': ['do not routinely measure plasma lamotrigine levels'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': ['do not routinely measure plasma lamotrigine levels unless there is evidence of ineffectiveness, poor adherence or toxicity'], 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['lamotrigine'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.10 How to use medication > Using lamotrigine > Stopping lamotrigine', 'original_recommendation_number': '1.10.39', 'original_recommendation_text': 'If stopping lamotrigine, reduce the dose gradually over at least 4 weeks to minimise the risk of relapse.', 'conditionality': ['if stopping lamotrigine'], 'action': ['reduce the dose gradually over at least 4 weeks'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': None, 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': ['lamotrigine'], 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.11 Recognition and diagnosing and managing bipolar disorder in children and young people > Recognition and referral', 'original_recommendation_number': '1.11.1', 'original_recommendation_text': 'Do not use questionnaires in primary care to identify bipolar disorder in children or young people.', 'conditionality': None, 'action': ['do not use questionnaires'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': None, 'age_group': 'child', 'prohibitions_and_cautions': ['do not use questionnaires'], 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.11 Recognition and diagnosing and managing bipolar disorder in children and young people > Recognition and referral', 'original_recommendation_number': '1.11.2', 'original_recommendation_text': 'If bipolar disorder is suspected in primary care in children or young people aged under 14 years, refer them to child and adolescent mental health services (CAMHS).', 'conditionality': None, 'action': ['refer'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': 'children or young people', 'age_group': 'child', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Recognition and referral', 'original_recommendation_number': '1.11.3', 'original_recommendation_text': 'If bipolar disorder is suspected in primary care in young people aged 14 years or over, refer them to a specialist early intervention in psychosis service or a CAMHS team with expertise in the assessment and management of bipolar disorder in line with the recommendations in this guideline. The service should be multidisciplinary and have:, and engagement or assertive outreach approaches, and family involvement and family intervention, and access to structured psychological interventions and psychologically informed care, and vocational and educational interventions, and access to pharmacological interventions, and professionals who are trained and competent in working with young people with bipolar disorder.', 'conditionality': ['if bipolar disorder is suspected'], 'action': ['refer them to a specialist early intervention in psychosis service or a CAMHS team with expertise in the assessment and management of bipolar disorder'], 'information_giving': None, 'clinical_setting': 'primary_care', 'population': 'young people', 'age_group': 'young_person', 'prohibitions_and_cautions': None, 'urgency': None, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': ['engagement or assertive outreach approaches', 'family involvement and family intervention', 'access to structured psychological interventions and psychologically informed care', 'vocational and educational interventions', 'access to pharmacological interventions'], 'care_coordination': None}, {'heading_context': '1.11 Recognition and diagnosing and managing bipolar disorder in children and young people > Recognition and referral > Diagnosis and assessment', 'original_recommendation_number': '1.11.4', 'original_recommendation_text': \"Diagnosis of bipolar disorder in children or young people should be made only after a period of intensive, prospective longitudinal monitoring by a healthcare professional or multidisciplinary team trained and experienced in the assessment, diagnosis and management of bipolar disorder in children and young people, and in collaboration with the child or young person's parents or carers.\", 'conditionality': ['by a healthcare professional or multidisciplinary team trained and experienced in the assessment, diagnosis and management of bipolar disorder in children and young people', \"in collaboration with the child or young person's parents or carers\"], 'action': ['make diagnosis'], 'information_giving': None, 'clinical_setting': None, 'population': 'children or young people', 'age_group': 'child', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Recognition and referral > Diagnosis and assessment', 'original_recommendation_number': '1.11.5', 'original_recommendation_text': 'When diagnosing bipolar disorder in children or young people take account of the following:, and mania must be present, and euphoria must be present on most days and for most of the time, for at least 7 days, and irritability is not a core diagnostic criterion.', 'conditionality': None, 'action': ['take account of the following'], 'information_giving': None, 'clinical_setting': None, 'population': 'children or young people', 'age_group': 'child', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': 'mania', 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.11 Recognition and diagnosing and managing bipolar disorder in children and young people > Recognition and referral > Diagnosis and assessment', 'original_recommendation_number': '1.11.6', 'original_recommendation_text': 'Do not make a diagnosis of bipolar disorder in children or young people on the basis of depression with a family history of bipolar disorder but follow them up.', 'conditionality': None, 'action': ['follow them up'], 'information_giving': None, 'clinical_setting': None, 'population': 'children or young people', 'age_group': 'child', 'prohibitions_and_cautions': ['do not make a diagnosis of bipolar disorder in children or young people on the basis of depression with a family history of bipolar disorder'], 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Recognition and referral > Diagnosis and assessment', 'original_recommendation_number': '1.11.7', 'original_recommendation_text': \"When assessing suspected bipolar disorder in children or young people, follow recommendations 1.3.2 to 1.3.4 for adults, but involve parents or carers routinely and take into account the child or young person's educational and social functioning.\", 'conditionality': None, 'action': ['follow recommendations', 'involve parents or carers', \"take into account the child or young person's educational and social functioning\"], 'information_giving': None, 'clinical_setting': 'assessment', 'population': 'children or young people', 'age_group': 'young_person', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Management in young people > Mania', 'original_recommendation_number': '1.11.9', 'original_recommendation_text': 'Aripiprazole is recommended as an option in NICE technology appraisal guidance for treating moderate to severe manic episodes in young people with bipolar I disorder. For full details, see the guidance on aripiprazole (TA292, 2013).', 'conditionality': None, 'action': ['treat'], 'information_giving': None, 'clinical_setting': None, 'population': 'young people', 'age_group': 'young_person', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': 'none', 'current_manic_phase': 'mania', 'symptom_severity': 'moderate', 'current_psychosis': 'null', 'diagnoses': ['bipolar I disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': ['aripiprazole'], 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.11 Recognising, diagnosing and managing bipolar disorder in children and young people > Management in young people > Mania', 'original_recommendation_number': '1.11.10', 'original_recommendation_text': \"When considering pharmacological interventions in young people, take into account the recommendations for adults in the section on managing mania or hypomania in adults in secondary care . Do not routinely continue antipsychotic treatment for longer than 12 weeks. Treatments recommended in the section on managing mania or hypomania in adults in secondary care may be off-label in young people. See NICE's information on prescribing medicines .\", 'conditionality': ['when considering pharmacological interventions in young people'], 'action': ['take into account the recommendations for adults', 'do not routinely continue antipsychotic treatment for longer than 12 weeks', 'treatments recommended in the section on managing mania or hypomania in adults may be off-label in young people'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': None, 'age_group': 'young_person', 'prohibitions_and_cautions': ['do not routinely continue antipsychotic treatment for longer than 12 weeks'], 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Management in young people > Mania', 'original_recommendation_number': '1.11.11', 'original_recommendation_text': 'Do not offer valproate to young people unless there is no other effective and tolerated treatment. Follow the MHRA safety measures and precautionary advice for valproate in box 1 .', 'conditionality': None, 'action': ['do not offer valproate'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': 'young_person', 'prohibitions_and_cautions': ['do not offer valproate unless there is no other effective and tolerated treatment'], 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': None, 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Management in young people > Bipolar depression', 'original_recommendation_number': '1.11.12', 'original_recommendation_text': \"Offer a structured psychological intervention (individual cognitive behavioural therapy or interpersonal therapy) to young people with bipolar depression. The intervention should be of at least 3 months' duration and have a published evidence-based manual describing how it should be delivered.\", 'conditionality': None, 'action': ['offer a structured psychological intervention'], 'information_giving': None, 'clinical_setting': None, 'population': 'young people', 'age_group': 'young_person', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': True, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Management in young people > Bipolar depression', 'original_recommendation_number': '1.11.13', 'original_recommendation_text': 'If after 4 to 6 weeks there is no or a limited response to cognitive behavioural therapy or interpersonal therapy, carry out a multidisciplinary review and consider an alternative individual or family psychological intervention.', 'conditionality': ['after 4 to 6 weeks'], 'action': ['carry out a multidisciplinary review', 'consider an alternative individual or family psychological intervention'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': 'young_person', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': True, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Management in young people > Bipolar depression', 'original_recommendation_number': '1.11.14', 'original_recommendation_text': 'If there is a risk of suicide or self‑harm or any other risk outlined in recommendation 1.3.5 , carry out an urgent review and develop a risk management plan as outlined in recommendation 1.4.1 .', 'conditionality': ['if there is a risk of suicide or self-harm or any other risk'], 'action': ['carry out an urgent review', 'develop a risk management plan'], 'information_giving': None, 'clinical_setting': None, 'population': None, 'age_group': 'young_person', 'prohibitions_and_cautions': None, 'urgency': True, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': 'self_harm', 'psychological_therapy': False, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Management in young people > Bipolar depression', 'original_recommendation_number': '1.11.15', 'original_recommendation_text': 'After the multidisciplinary review, if there are coexisting factors such as comorbid conditions, persisting psychosocial risk factors such as family discord, or parental mental ill‑health, consider:, and an alternative psychological intervention for bipolar depression for the young person, their parents or other family member or or, and an additional psychological intervention for any coexisting mental health problems in line with relevant NICE guidance for the young person, their parents or other family member.', 'conditionality': ['if there are coexisting factors such as comorbid conditions, persisting psychosocial risk factors such as family discord, or parental mental ill-health'], 'action': ['consider an alternative psychological intervention for bipolar depression', 'consider an additional psychological intervention for any coexisting mental health problems'], 'information_giving': None, 'clinical_setting': None, 'population': 'young person, their parents or other family member', 'age_group': 'young_person', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': True, 'other_treatments': None, 'care_coordination': None}, {'heading_context': 'Management in young people > Bipolar depression', 'original_recommendation_number': '1.11.16', 'original_recommendation_text': \"If the young person's bipolar depression is moderate to severe, consider a pharmacological intervention in addition to a psychological intervention. Take into account the recommendations for adults in the section on managing bipolar depression in adults in secondary care . Do not routinely continue antipsychotic treatment for longer than 12 weeks. At 12 weeks, carry out a full multidisciplinary review of mental and physical health, and consider further management of depression or long‑term management. Treatments recommended in the section on managing bipolar depression in adults in secondary care may be off-label in young people. See NICE's information on prescribing medicines .\", 'conditionality': [\"if the young person's bipolar depression is moderate to severe\"], 'action': ['consider a pharmacological intervention in addition to a psychological intervention', 'carry out a full multidisciplinary review of mental and physical health', 'consider further management of depression or long-term management'], 'information_giving': None, 'clinical_setting': 'secondary_care', 'population': 'young people', 'age_group': 'young_person', 'prohibitions_and_cautions': ['do not routinely continue antipsychotic treatment for longer than 12 weeks'], 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': 'moderate to severe', 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': True, 'other_treatments': None, 'care_coordination': None}, {'heading_context': '1.11 Recognising, diagnosing and managing bipolar disorder in children and young people > Management in young people > Long-term management', 'original_recommendation_number': '1.11.17', 'original_recommendation_text': 'After the multidisciplinary review, consider a structured individual or family psychological intervention for managing bipolar disorder in young people in the longer term.', 'conditionality': ['after the multidisciplinary review'], 'action': ['consider a structured individual or family psychological intervention'], 'information_giving': None, 'clinical_setting': None, 'population': 'young people', 'age_group': 'young_person', 'prohibitions_and_cautions': None, 'urgency': False, 'manic_episode_history': None, 'current_manic_phase': None, 'symptom_severity': None, 'current_psychosis': None, 'diagnoses': ['bipolar disorder'], 'current_medication': None, 'medication_adherence': None, 'suggested_medication': None, 'physical_health_longterm': None, 'physical_health_recent': None, 'risk': None, 'psychological_therapy': True, 'other_treatments': None, 'care_coordination': None}]\n"
          ]
        },
        {
          "output_type": "error",
          "ename": "IsADirectoryError",
          "evalue": "[Errno 21] Is a directory: '/content/drive/My Drive/Colab Notebooks/Dissertation/JSON/patient_schema.json'",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mIsADirectoryError\u001b[0m                         Traceback (most recent call last)",
            "\u001b[0;32m/tmp/ipython-input-2673221228.py\u001b[0m in \u001b[0;36m<cell line: 0>\u001b[0;34m()\u001b[0m\n\u001b[1;32m     14\u001b[0m \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mguideline_structured\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     15\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 16\u001b[0;31m \u001b[0mpatient_schema\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mload_json\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mLOAD_PATIENT_SCHEMA\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     17\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     18\u001b[0m \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mtype\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mpatient_schema\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/tmp/ipython-input-2673221228.py\u001b[0m in \u001b[0;36mload_json\u001b[0;34m(file_path)\u001b[0m\n\u001b[1;32m      3\u001b[0m \u001b[0;32mdef\u001b[0m \u001b[0mload_json\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mfile_path\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      4\u001b[0m     \u001b[0;32mtry\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 5\u001b[0;31m         \u001b[0;32mwith\u001b[0m \u001b[0mopen\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mfile_path\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m\"r\"\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mencoding\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m\"utf-8\"\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0mf\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      6\u001b[0m             \u001b[0;32mreturn\u001b[0m \u001b[0mjson\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mload\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mf\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      7\u001b[0m     \u001b[0;32mexcept\u001b[0m \u001b[0mFileNotFoundError\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mIsADirectoryError\u001b[0m: [Errno 21] Is a directory: '/content/drive/My Drive/Colab Notebooks/Dissertation/JSON/patient_schema.json'"
          ]
        }
      ],
      "source": [
        "# Load JSON\n",
        "\n",
        "def load_json(file_path):\n",
        "    try:\n",
        "        with open(file_path, \"r\", encoding=\"utf-8\") as f:\n",
        "            return json.load(f)\n",
        "    except FileNotFoundError:\n",
        "        raise FileNotFoundError(f'JSON file not found: {file_path}')\n",
        "\n",
        "guideline_structured = load_json(LOAD_GUIDELINE_STRUCTURED)\n",
        "\n",
        "print(type(guideline_structured))\n",
        "print(len(guideline_structured))\n",
        "print(guideline_structured)\n",
        "\n",
        "patient_schema = load_json(LOAD_PATIENT_SCHEMA)\n",
        "\n",
        "print(type(patient_schema))\n",
        "print(len(patient_schema))\n",
        "print(patient_schema[0])"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Create record of exact guideline version extracted with metadata\n",
        "\"\"\"In case of future runs with differernt guidelines and structure\n",
        "Then problems with a run can be traced precisely\"\"\"\n",
        "- guideline name\n",
        "- html\n",
        "- scrape date"
      ],
      "metadata": {
        "id": "jXvkbEtTDhNQ"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Save local copy of JSON with metadata\n",
        "- protect the file somehow from being overwritten or edited?"
      ],
      "metadata": {
        "id": "QY2f6B38EKFT"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Create an index or summary for the JSON to enable more reliable searching by the state manager?"
      ],
      "metadata": {
        "id": "ksFqOfMZEghF"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "#### NOTE\n",
        "\"\"\"\n",
        "If the question being asked tessellates with a particular section (e.g., a medication)\n",
        "it may be worth flagging other areas (e.g., carer support.. physical health...)\n",
        "The model may need to supply back to the user a list of \"have you also considered...\" making use of these headings\n",
        "to prevent a narrow focus on the main content of the question\n",
        "and ensure that other recommendation sections are also being considered\n",
        "\"\"\""
      ],
      "metadata": {
        "id": "zpCccgHf-4fO"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def get_user_message():\n",
        "    \"\"\"\n",
        "    Uses a UI like Streamlit or an API to send and receive messages\n",
        "    \"\"\"\n",
        "\n",
        "    # From https://www.geeksforgeeks.org/python/create-a-chatbot-with-openai-and-streamlit-in-python/\n",
        "    st.title(&quot;NICE GUIDELINE CHATBOT&quot;)\n",
        "    if 'user_input' not in st.session_state:\n",
        "        st.session_state['user_input'] = []\n",
        "\n",
        "    if 'openai_response' not in st.session_state:\n",
        "        st.session_state['openai_response'] = []\n",
        "\n",
        "    def get_text():\n",
        "        input_text = st.text_input(&quot;Enter your question and patient information here:&quot;, key=&quot;input&quot;)\n",
        "        return input_text\n",
        "\n",
        "    user_input = get_text()\n",
        "\n",
        "    if user_input:\n",
        "        output = api_calling(user_input)\n",
        "        output = output.lstrip(&quot;\\n&quot;)\n",
        "\n",
        "        # Store the output\n",
        "        st.session_state.openai_response.append(user_input)\n",
        "        st.session_state.user_input.append(output)\n"
      ],
      "metadata": {
        "id": "y7eaW6NDQNgi"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def call_llm(prompt):\n",
        "    \"\"\"\n",
        "    General function for call to the LLM\n",
        "    What is passed to the LLM (\"prompt\") is decided by other functions\n",
        "    \"\"\"\n",
        "\n",
        "    inputs = tokenizer(prompt,\n",
        "                       return_tensors=\"pt\").to(model.device)\n",
        "\n",
        "    outputs = model.generate(**inputs,\n",
        "                             max_new_tokens=500,\n",
        "                             do_sample=False) # deterministic decoding without random sampling\n",
        "                                            # if removed, reinstate temperature / top_p / top_k\n",
        "\n",
        "    llm_response = tokenizer.batch_decode(outputs[:, inputs[\"input_ids\"].shape[1]:],\n",
        "                                          skip_special_tokens=True)\n",
        "\n",
        "    return llm_response[0]"
      ],
      "metadata": {
        "id": "0KF92-48cSRP"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def extract_patient_facts(user_input):\n",
        "\n",
        "    # At some point need to decide whether this should output patient_facts variable\n",
        "    # ... or store the output in a predefined and loaded patient_schema.json\n",
        "\n",
        "    # age_group is not being populated correctly yet\n",
        "\n",
        "    ########### SEE NEW ADDITION FIELDS TO PROMPT AND HARMONISE\n",
        "    #### INCLUDING POPULATING VALIDATION LIST LOWER DOWN IN PROMPT\n",
        "\n",
        "    \"\"\"\n",
        "    Use LLM to decompose message into fields captured by JSON-keys\n",
        "    \"\"\"\n",
        "\n",
        "    prompt = f\"\"\"You are extracting structured information from USER INPUT.\n",
        "\n",
        "                RULES:\n",
        "                - output must be valid JSON only (no markdown)\n",
        "                - do not invent or infer clinical information; use only what is present in the user input\n",
        "                - For ALL clinical descriptor fields (e.g. phase, severity, medication): populate a value ONLY if it is explicitly stated in the user input. Do NOT infer information that is not directly stated. If not explicit, use null.\n",
        "                - 'age' must be an integer\n",
        "                - 'age_group' must be assigned from 'age' using these rules:\n",
        "                    - if age < 12: 'child'\n",
        "                    - if age >= 13 and age <= 17: 'young_person'\n",
        "                    - if age >= 65: 'older_adult'\n",
        "                    - otherwise: 'adult'\n",
        "                - 'gender' must be one of: ['male', 'female', 'other', null]\n",
        "                - Extract 'urgency' as 'True' if the text includes 'urgent', 'urgently', 'immediate' or 'immediately', otherwise 'False'\n",
        "                - 'manic_episode_history' must be one of: ['none', 'one', 'multiple', null]\n",
        "                - 'current_manic_phase' must be one of: ['mania', 'hypomania', 'depression', 'mixed', 'rapid_cycling', 'euthymic', null]\n",
        "                - 'symptom_severity' must be one of: ['mild', 'moderate', 'severe', null]\n",
        "                - 'current_psychosis' must be: ['present', 'absent', null]\n",
        "                - 'diagnoses' must be one or more comorbid mental health diagnoses. If more than one diagnosis is mentioned, record all as a list of strings.\n",
        "                - 'current_medication' must be a medication name or null. If more than one medication is mentioned, record all as a list of strings.\n",
        "                #- 'current_medication_class'\n",
        "                #- 'current_medication_dosage'\n",
        "                #- 'current_medication_frequency'\n",
        "                #- 'negative_side_effects'\n",
        "                # - 'treatment_stage' -> stopping/starting medication, post assessment etc....\n",
        "                # - 'treatment_response'\n",
        "                # - 'test_results'\n",
        "                - 'medication_adherence' must be one of: ['good', 'poor', null]\n",
        "                #- 'previous_medications_tried'\n",
        "                - 'physical_health_longterm' must be the name of a physical disease diagnosis that affects a person for more than six months. If more than one diagnosis is mentioned, record all as a list of strings.\n",
        "                - 'physical_health_recent' must be the name of a transient disease (less than six months) or physical health event from the last six months. If more than one diagnosis is mentioned, record all as a list of strings.\n",
        "                - 'risk' must be one of: ['self_harm', 'risk_to_others', null]\n",
        "                - If 'psychological_therapy' is mentioned in the user input, set to True, otherwise False.\n",
        "                #- 'psychological_therapy_type' must be one of: ['psychodynamic', 'psychoeducation', 'cognitive_behavioural', 'other', null]\n",
        "                # -'psychological_therapy_delivery' must be one of: ['individual', 'group', null]\n",
        "                #- 'attitude_towards_psychological_therapy' must be one of: ['positive', 'ambivalent', 'negative', null]\n",
        "                - 'clinical_setting' must be one of: ['assessment', 'primary_care', 'secondary_care', 'inpatient', null]\n",
        "                - Set 'has_carer' to True if USER INPUT mentions the involvement or concern of a friend, family member, partner or official carer. Otherwise set to False.\n",
        "                - 'care_coordination' must be one of: ['current', 'offered', null]\n",
        "                #- 'advanced_statement_present' must be set to True if the patient has made an official personal plan of care wishes for future crises, otherwise set to False.\n",
        "                - 'patient_preference' is a string describing what the patient has requested or expressed a preference for. If no preference is stated, record null.\n",
        "\n",
        "                Produce JSON with exactly these keys:\n",
        "###############################populate\n",
        "\n",
        "                REMEMBER:\n",
        "                - you MUST use 'null' if the information for any field is not explicit in the recommendation or heading\n",
        "                - if there is more than one value for any field, retain all as a list of strings\n",
        "\n",
        "                USER INPUT: {user_input}\n",
        "                \"\"\"\n",
        "\n",
        "    inputs = tokenizer(prompt,\n",
        "                       return_tensors=\"pt\").to(model.device)\n",
        "\n",
        "    outputs = model.generate(**inputs,\n",
        "                             max_new_tokens=500,\n",
        "\n",
        "                             do_sample=False) # deterministic decoding without random sampling\n",
        "                                            # if removed, reinstate temperature / top_p / top_k\n",
        "\n",
        "    patient_facts = tokenizer.batch_decode(outputs[:, inputs[\"input_ids\"].shape[1]:],\n",
        "                                          skip_special_tokens=True)\n",
        "\n",
        "    return patient_facts[0]"
      ],
      "metadata": {
        "id": "OUKvTzrzZqIu"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "\n",
        "\n",
        "\n",
        "\n",
        "# Patient entry needs medcat normalisation\n",
        "\n"
      ],
      "metadata": {
        "id": "gGJ4zvofUdff"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Test of conversion to patient facts\n",
        "\n",
        "user_input_test = \"\"\"The patient is a 23-year-old woman with suspected bipolar disorder -\n",
        "                    though we are still waiting for the duty psychiatrist to confirm this -\n",
        "                    as well as previous diagnoses of borderline personality disorder and ADHD.\n",
        "                    She is currently under the local secondary care team after an admission eight months ago,\n",
        "                    when she was presenting as aggressive and with grandiose ideas about\n",
        "                    being a religious prophet. She was prescribed lithium but, according to the\n",
        "                    team, she has not been taking it consistently because she doesn't like the\n",
        "                    drowsiness. We're concerned about her because, recently, she has presented\n",
        "                    as more irritable again and once threatened our deputy manager with kidnap,\n",
        "                    saying that she could tell he was possessed by a demon. She says she hasn't\n",
        "                    been sleeping for one week. The GP reported that she smelt strongly of alcohol\n",
        "                    when seen there. The patient says she doesn't want to go back to hospital.\n",
        "                    Should we considering increasing her lithium?\"\"\"\n",
        "\n",
        "patient_facts_test = extract_patient_facts(user_input_test)\n",
        "\n",
        "print(patient_facts_test)"
      ],
      "metadata": {
        "id": "riUCresqw2nl"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "user_input_test = \"\"\"The patient is a 38-year-old man with a confirmed diagnosis of\n",
        "                    bipolar II disorder, managed in primary care with intermittent\n",
        "                    secondary care input. He has a history of recurrent depressive episodes\n",
        "                    and brief hypomanic periods but no previous psychosis or admissions.\n",
        "                    He is currently prescribed sertraline by his GP, which was restarted\n",
        "                    six months ago following a prolonged low mood, reduced motivation,\n",
        "                    and social withdrawal. He reports feeling flat but less suicidal\n",
        "                    since restarting the antidepressant. Over the past three weeks, however,\n",
        "                    he has been sleeping only four hours a night, feels more restless,\n",
        "                    and has started several unrealistic business ideas, though he denies\n",
        "                    feeling euphoric. There is no mood stabiliser in place. Is continuing\n",
        "                    antidepressant monotherapy appropriate?\"\"\"\n",
        "\n",
        "patient_facts_test = extract_patient_facts(user_input_test)\n",
        "\n",
        "print(patient_facts_test)"
      ],
      "metadata": {
        "id": "IouVWmb2AcxT"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "user_input_test = \"\"\"The patient is a 57-year-old woman with a long-standing diagnosis\n",
        "                of bipolar I disorder, currently euthymic and living independently.\n",
        "                She has been stable for several years on lithium, which has previously been\n",
        "                highly effective in preventing relapse. Recent blood tests, however, show a\n",
        "                decline in renal function, and her GP is concerned about the long-term\n",
        "                safety of continuing lithium. The patient is anxious about medication\n",
        "                changes, as her last manic episode prior to lithium resulted in significant\n",
        "                financial losses and hospitalisation. She denies current mood symptoms\n",
        "                and is adherent with treatment. Is continuing lithium appropriate and\n",
        "                what alternative maintenance strategies would be recommended given\n",
        "                emerging physical health risks?\"\"\"\n",
        "\n",
        "patient_facts_test = extract_patient_facts(user_input_test)\n",
        "\n",
        "print(patient_facts_test)"
      ],
      "metadata": {
        "id": "dDtGrRdhAfHM"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "\n",
        "\n",
        "\n",
        "\n",
        "# 27/01/2026 - update field list once the prompt has been finalised.\n",
        "# The fields below are not the full set\n",
        "\n",
        "\n",
        "def select_relevant_recommendations(patient_facts, guideline_structured):\n",
        "    \"\"\"\n",
        "    Based on matches between decomposed user input and guideline_structured.json\n",
        "    \"\"\"\n",
        "\n",
        "    matching_constrained_keys = []\n",
        "    matching_unconstrained_keys = []\n",
        "\n",
        "    relevant_recommendations = [] # Should be compiled with headings and numbers as well as text\n",
        "\n",
        "    for i, entity in enumerate(guideline_structured):\n",
        "\n",
        "        for key, value in patient_facts.items():\n",
        "            if key not in entity:\n",
        "                continue # because some keys are not shared (there are more in the recommendation entities)\n",
        "\n",
        "            patient_facts_key = patient_facts[key]\n",
        "            entity_key = entity[key]\n",
        "\n",
        "            # For boolean fields or those with constrained values\n",
        "            \"\"\"\n",
        "            age_group\n",
        "            urgency\n",
        "            manic_episode_history\n",
        "            current_manic_phase\n",
        "            symptom_severity\n",
        "            current_psychosis\n",
        "            medication_adherence\n",
        "            risk\n",
        "            psychological_therapy\n",
        "            clinical_setting\n",
        "            care_coordination\n",
        "            \"\"\"\n",
        "            if patient_facts_key == entity_key and patient_facts_key != False and patient_facts_key != None:\n",
        "                matching_constrained_keys.append((key, value))\n",
        "                relevant_recommendations.append({\n",
        "                    'original_recommendation_number': entity['original_recommendation_number'],\n",
        "                    'heading_context': entity['heading_context'],\n",
        "                    'original_recommendation_text': entity['original_recommendation_text']})\n",
        "\n",
        "            # For free text fields where the keys match but not necessarily the value\n",
        "            \"\"\"\n",
        "            diagnoses\n",
        "            current_medication\n",
        "            physical_health_longterm\n",
        "            physical_health_recent\n",
        "            \"\"\"\n",
        "            elif patient_facts_key == entity_key and patient_facts_key != False and patient_facts_key != None:\n",
        "                matching_unconstrained_keys.append((key))\n",
        "                relevant_recommendations.append({\n",
        "                    'original_recommendation_number': entity['original_recommendation_number'],\n",
        "                    'heading_context': entity['heading_context'],\n",
        "                    'original_recommendation_text': entity['original_recommendation_text']})\n",
        "\n",
        "            # Retain patient preferences?\n",
        "\n",
        "    return matching_constrained_keys, relevant_recommendations"
      ],
      "metadata": {
        "id": "l_4yp2BgQb_F",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 87
        },
        "outputId": "e8e746b1-ebf7-412a-bed4-be934332b314"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'\\nEXACT MATCHES\\nage_group\\nurgency\\nmanic_episode_history\\ncurrent_manic_phase\\nsymptom_severity\\ncurrent_psychosis\\nmedication_adherence\\nrisk\\npsychological_therapy\\nclinical_setting\\ncare_coordination\\n\\nFOR MATCHING STRINGS WITHIN LISTS\\ndiagnoses\\ncurrent_medication\\nphysical_health_longterm\\nphysical_health_recent\\n\\nINCLUDE\\npatient_preferences\\n'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 41
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Just to have a variable with some patient facts in for testing the relevant_recommendations function\n",
        "# So as not to have to load LLM / use GPU each time\n",
        "\n",
        "patient_facts = {\n",
        "    \"age\": 57,\n",
        "    \"age_group\": \"older_adult\",\n",
        "    \"gender\": \"female\",\n",
        "    \"urgency\": True,\n",
        "    \"manic_episode_history\": \"one\",\n",
        "    \"current_manic_phase\": \"euthymic\",\n",
        "    \"symptom_severity\": \"moderate\",\n",
        "    \"current_psychosis\": \"absent\",\n",
        "    \"diagnoses\": [\"bipolar I disorder\"],\n",
        "    \"current_medication\": [\"lithium\"],\n",
        "    \"medication_adherence\": \"poor\",\n",
        "    \"physical_health_longterm\": [\"renal function decline\"],\n",
        "    \"physical_health_recent\": None,\n",
        "    \"risk\": 'risk_to_others',\n",
        "    \"psychological_therapy\": None,\n",
        "    \"clinical_setting\": \"primary_care\",\n",
        "    \"care_coordination\": None,\n",
        "    \"patient_preferences\": None\n",
        "}\n",
        "\n",
        "json.dumps(patient_facts)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 105
        },
        "id": "icTZsv1wnTVz",
        "outputId": "6ced5ed7-d137-4a45-f4af-a079ad957fa1"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'{\"age\": 57, \"age_group\": \"older_adult\", \"gender\": \"female\", \"urgency\": true, \"manic_episode_history\": \"one\", \"current_manic_phase\": \"euthymic\", \"symptom_severity\": \"moderate\", \"current_psychosis\": \"absent\", \"diagnoses\": [\"bipolar I disorder\"], \"current_medication\": [\"lithium\"], \"medication_adherence\": \"poor\", \"physical_health_longterm\": [\"renal function decline\"], \"physical_health_recent\": null, \"risk\": \"risk_to_others\", \"psychological_therapy\": null, \"clinical_setting\": \"primary_care\", \"care_coordination\": null, \"patient_preferences\": null}'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 59
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Test\n",
        "\n",
        "relevant_recommendations = select_relevant_recommendations(patient_facts, guideline_structured)\n",
        "\n",
        "print(relevant_recommendations)"
      ],
      "metadata": {
        "id": "dgV8rz3I08gt",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "744a78e2-b44e-4238-8480-f254f1bf9faf"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "patient_facts_key: older_adult\n",
            "entity_key: older_adult\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: poor\n",
            "entity_key: poor\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: ['lithium']\n",
            "entity_key: ['lithium']\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: True\n",
            "entity_key: True\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: ['lithium']\n",
            "entity_key: ['lithium']\n",
            "patient_facts_key: ['lithium']\n",
            "entity_key: ['lithium']\n",
            "patient_facts_key: one\n",
            "entity_key: one\n",
            "patient_facts_key: ['lithium']\n",
            "entity_key: ['lithium']\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: older_adult\n",
            "entity_key: older_adult\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: ['lithium']\n",
            "entity_key: ['lithium']\n",
            "patient_facts_key: ['lithium']\n",
            "entity_key: ['lithium']\n",
            "patient_facts_key: ['lithium']\n",
            "entity_key: ['lithium']\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: ['lithium']\n",
            "entity_key: ['lithium']\n",
            "patient_facts_key: older_adult\n",
            "entity_key: older_adult\n",
            "patient_facts_key: poor\n",
            "entity_key: poor\n",
            "patient_facts_key: ['lithium']\n",
            "entity_key: ['lithium']\n",
            "patient_facts_key: ['lithium']\n",
            "entity_key: ['lithium']\n",
            "patient_facts_key: ['lithium']\n",
            "entity_key: ['lithium']\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: ['lithium']\n",
            "entity_key: ['lithium']\n",
            "patient_facts_key: ['lithium']\n",
            "entity_key: ['lithium']\n",
            "patient_facts_key: True\n",
            "entity_key: True\n",
            "patient_facts_key: older_adult\n",
            "entity_key: older_adult\n",
            "patient_facts_key: True\n",
            "entity_key: True\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: primary_care\n",
            "entity_key: primary_care\n",
            "patient_facts_key: moderate\n",
            "entity_key: moderate\n",
            "patient_facts_key: ['bipolar I disorder']\n",
            "entity_key: ['bipolar I disorder']\n",
            "patient_facts_key: True\n",
            "entity_key: True\n",
            "([('age_group', 'older_adult'), ('clinical_setting', 'primary_care'), ('clinical_setting', 'primary_care'), ('clinical_setting', 'primary_care'), ('clinical_setting', 'primary_care'), ('clinical_setting', 'primary_care'), ('clinical_setting', 'primary_care'), ('medication_adherence', 'poor'), ('clinical_setting', 'primary_care'), ('clinical_setting', 'primary_care'), ('clinical_setting', 'primary_care'), ('current_medication', ['lithium']), ('clinical_setting', 'primary_care'), ('urgency', True), ('clinical_setting', 'primary_care'), ('clinical_setting', 'primary_care'), ('current_medication', ['lithium']), ('current_medication', ['lithium']), ('manic_episode_history', 'one'), ('current_medication', ['lithium']), ('clinical_setting', 'primary_care'), ('clinical_setting', 'primary_care'), ('clinical_setting', 'primary_care'), ('age_group', 'older_adult'), ('clinical_setting', 'primary_care'), ('current_medication', ['lithium']), ('current_medication', ['lithium']), ('current_medication', ['lithium']), ('clinical_setting', 'primary_care'), ('current_medication', ['lithium']), ('age_group', 'older_adult'), ('medication_adherence', 'poor'), ('current_medication', ['lithium']), ('current_medication', ['lithium']), ('current_medication', ['lithium']), ('clinical_setting', 'primary_care'), ('current_medication', ['lithium']), ('current_medication', ['lithium']), ('urgency', True), ('age_group', 'older_adult'), ('urgency', True), ('clinical_setting', 'primary_care'), ('clinical_setting', 'primary_care'), ('clinical_setting', 'primary_care'), ('symptom_severity', 'moderate'), ('diagnoses', ['bipolar I disorder']), ('urgency', True)], [{'original_recommendation_number': '1.1.1', 'heading_context': '1.1 Care for adults, children and young people across all phases of bipolar disorder > Treatment and support for specific populations', 'original_recommendation_text': 'Ensure that older people with bipolar disorder are offered the same range of treatments and services as younger people with bipolar disorder.'}, {'original_recommendation_number': '1.2.1', 'heading_context': 'Recognising and managing bipolar disorder in adults in primary care', 'original_recommendation_text': 'When adults present in primary care with depression , ask about previous periods of overactivity or disinhibited behaviour. If the overactivity or disinhibited behaviour lasted for 4 days or more, consider referral for a specialist mental health assessment.'}, {'original_recommendation_number': '1.2.3', 'heading_context': 'Recognising and managing bipolar disorder in adults in primary care > Recognising bipolar disorder in primary care and referral', 'original_recommendation_text': 'Do not use questionnaires in primary care to identify bipolar disorder in adults.'}, {'original_recommendation_number': '1.2.4', 'heading_context': 'Managing bipolar disorder in primary care', 'original_recommendation_text': 'When working with people with bipolar disorder in primary care:, and support them to carry out care plans developed in secondary care and achieve their recovery goals, and follow crisis plans developed in secondary care and liaise with secondary care specialists if necessary, and review their treatment and care, including medication, at least annually and more often if the person, carer or healthcare professional has any concerns.'}, {'original_recommendation_number': '1.2.6', 'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care > Managing bipolar disorder in primary care', 'original_recommendation_text': 'Psychological therapists working with people with bipolar depression in primary care should have training in and experience of working with people with bipolar disorder.'}, {'original_recommendation_number': '1.2.7', 'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care > Managing bipolar disorder in primary care', 'original_recommendation_text': 'Do not start lithium to treat bipolar disorder in primary care for people who have not taken lithium before, except under shared-care arrangements.'}, {'original_recommendation_number': '1.2.8', 'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care > Managing bipolar disorder in primary care', 'original_recommendation_text': 'Do not start valproate in primary care to treat bipolar disorder.'}, {'original_recommendation_number': '1.2.9', 'heading_context': 'Managing bipolar disorder in primary care', 'original_recommendation_text': \"If bipolar disorder is managed solely in primary care, re-refer to secondary care if any one of the following applies:, and there is a poor or partial response to treatment, and the person's functioning declines significantly, and treatment adherence is poor, and the person develops intolerable or medically important side effects from medication, and comorbid alcohol or drug misuse is suspected, and the person is considering stopping any medication after a period of relatively stable mood, and a woman with bipolar disorder is pregnant or planning a pregnancy.\"}, {'original_recommendation_number': '1.2.9', 'heading_context': 'Managing bipolar disorder in primary care', 'original_recommendation_text': \"If bipolar disorder is managed solely in primary care, re-refer to secondary care if any one of the following applies:, and there is a poor or partial response to treatment, and the person's functioning declines significantly, and treatment adherence is poor, and the person develops intolerable or medically important side effects from medication, and comorbid alcohol or drug misuse is suspected, and the person is considering stopping any medication after a period of relatively stable mood, and a woman with bipolar disorder is pregnant or planning a pregnancy.\"}, {'original_recommendation_number': '1.2.10', 'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'original_recommendation_text': 'Develop and use practice case registers to monitor the physical and mental health of people with bipolar disorder in primary care.'}, {'original_recommendation_number': '1.2.11', 'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'original_recommendation_text': 'Monitor the physical health of people with bipolar disorder when responsibility for monitoring is transferred from secondary care, and then at least annually. The health check should be comprehensive, including all the checks recommended in recommendation 1.2.12 and focusing on physical health problems such as cardiovascular disease, diabetes, obesity and respiratory disease. A copy of the results should be sent to the care coordinator and psychiatrist, and put in the secondary care records.'}, {'original_recommendation_number': '1.2.12', 'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'original_recommendation_text': 'Ensure that the physical health check for people with bipolar disorder, performed at least annually, includes:, and weight or BMI, diet, nutritional status and level of physical activity, and cardiovascular status, including pulse and blood pressure, and metabolic status, including fasting blood glucose or glycosylated haemoglobin (HbA1c), and blood lipid profile, and liver function, and renal and thyroid function, and calcium levels, for people taking long-term lithium.'}, {'original_recommendation_number': '1.2.12', 'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'original_recommendation_text': 'Ensure that the physical health check for people with bipolar disorder, performed at least annually, includes:, and weight or BMI, diet, nutritional status and level of physical activity, and cardiovascular status, including pulse and blood pressure, and metabolic status, including fasting blood glucose or glycosylated haemoglobin (HbA1c), and blood lipid profile, and liver function, and renal and thyroid function, and calcium levels, for people taking long-term lithium.'}, {'original_recommendation_number': '1.2.13', 'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'original_recommendation_text': \"Identify people with bipolar disorder who have hypertension, have abnormal lipid levels, are obese or at risk of obesity, have diabetes or are at risk of diabetes (as indicated by abnormal blood glucose levels), or are physically inactive, at the earliest opportunity. Follow NICE's guidelines on hypertension , cardiovascular disease: risk assessment and reduction, including lipid modification , prevention of cardiovascular disease , overweight and obesity management , physical activity and preventing type 2 diabetes .\"}, {'original_recommendation_number': '1.2.13', 'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'original_recommendation_text': \"Identify people with bipolar disorder who have hypertension, have abnormal lipid levels, are obese or at risk of obesity, have diabetes or are at risk of diabetes (as indicated by abnormal blood glucose levels), or are physically inactive, at the earliest opportunity. Follow NICE's guidelines on hypertension , cardiovascular disease: risk assessment and reduction, including lipid modification , prevention of cardiovascular disease , overweight and obesity management , physical activity and preventing type 2 diabetes .\"}, {'original_recommendation_number': '1.2.14', 'heading_context': '1.2 Recognising and managing bipolar disorder in adults in primary care', 'original_recommendation_text': \"Offer treatment to people with bipolar disorder who have diabetes and/or cardiovascular disease in primary care in line with NICE's guidelines on type 1 diabetes in adults: diagnosis and management , type 2 diabetes in adults: management and cardiovascular disease: risk assessment and reduction, including lipid modification .\"}, {'original_recommendation_number': '1.5.6', 'heading_context': '1.5 Managing mania or hypomania in adults in secondary care', 'original_recommendation_text': \"If adding lithium is ineffective, or if lithium is not suitable (for example, because the person does not agree to routine blood monitoring), consider adding valproate instead. Follow the MHRA safety measures and precautionary advice for valproate in box 1 . In September 2025 semi-sodium valproate had a UK marketing authorisation for the treatment of mania if lithium is not tolerated or is contraindicated; use of other formulations of valproate would be off-label, although use is common in UK clinical practice. See NICE's information on prescribing medicines .\"}, {'original_recommendation_number': '1.5.8', 'heading_context': '1.5 Managing mania or hypomania in adults in secondary care', 'original_recommendation_text': \"If the person is already taking lithium, check plasma lithium levels to optimise treatment (see the section on how to use medication ). Consider adding haloperidol, olanzapine, quetiapine or risperidone, depending on the person's preference and previous response to treatment.\"}, {'original_recommendation_number': '1.7.5', 'heading_context': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'original_recommendation_text': 'When planning long-term pharmacological treatment to prevent relapse, take into account drugs that have been effective during episodes of mania or bipolar depression. Discuss with the person whether they prefer to continue this treatment or switch to lithium, and explain that lithium is the most effective long-term treatment for bipolar disorder.'}, {'original_recommendation_number': '1.7.8', 'heading_context': '1.7 Managing bipolar disorder in adults in the longer term in secondary care', 'original_recommendation_text': 'If lithium is ineffective, poorly tolerated, or is not suitable (for example, because the person does not agree to routine blood monitoring), consider an antipsychotic (for example, asenapine, aripiprazole, olanzapine, quetiapine or risperidone).'}, {'original_recommendation_number': '1.9.3', 'heading_context': '1.9 Promoting recovery and return to primary care > Return to primary care', 'original_recommendation_text': 'Offer people with bipolar disorder whose symptoms have responded effectively to treatment and remain stable the option to return to primary care for further management. If they wish to do this, record it in their notes and coordinate transfer of responsibilities through the care programme approach.'}, {'original_recommendation_number': '1.9.4', 'heading_context': '1.9 Promoting recovery and return to primary care > Return to primary care', 'original_recommendation_text': \"When making transfer arrangements for a return to primary care, agree a care plan with the person, which includes:, and clear, individualised social and emotional recovery goals, and a crisis plan indicating early warning symptoms and triggers of both mania and depression relapse and preferred response during relapse, including liaison and referral pathways, and an assessment of the person's mental state, and a medication plan with a date for review by primary care, frequency and nature of monitoring for effectiveness and adverse effects, and what should happen in the event of a relapse. Give the person and their GP a copy of the plan, and encourage the person to share it with their carers .\"}, {'original_recommendation_number': '1.9.5', 'heading_context': '1.9 Promoting recovery and return to primary care > Return to primary care', 'original_recommendation_text': 'Encourage and support the person to visit their GP and discuss the care plan before discharge and transfer.'}, {'original_recommendation_number': '1.10.3', 'heading_context': '1.10 How to use medication', 'original_recommendation_text': 'When offering psychotropic medication to older people , take into account its impact on cognitive functioning in older people and:, and use medication at lower doses, and take into account the increased risk of drug interactions, and take into account the negative impact that anticholinergic medication, or drugs with anticholinergic activity, can have on cognitive function and mobility, and ensure that medical comorbidities have been recognised and treated.'}, {'original_recommendation_number': '1.10.14', 'heading_context': '1.10 How to use medication > Using lithium > Starting lithium', 'original_recommendation_text': \"When starting lithium:, and advise the person that poor adherence or rapid discontinuation may increase the risk of relapse, and measure the person's weight or BMI and arrange tests for urea and electrolytes including calcium, estimated glomerular filtration rate (eGFR), thyroid function and a full blood count, and arrange an ECG for people with cardiovascular disease or risk factors for it, and ensure the person is given appropriate national information (or a locally available equivalent) on taking lithium safely, and establish a shared‑care arrangement with the person's GP for prescribing lithium and monitoring adverse effects.\"}, {'original_recommendation_number': '1.10.15', 'heading_context': '1.10 How to use medication > Using lithium > Starting lithium', 'original_recommendation_text': 'Measure plasma lithium levels 1 week after starting lithium and 1 week after every dose change, and weekly until the levels are stable. Aim to maintain plasma lithium level between 0.6 and 0.8 mmol per litre in people being prescribed lithium for the first time.'}, {'original_recommendation_number': '1.10.16', 'heading_context': '1.10 How to use medication > Using lithium > Starting lithium', 'original_recommendation_text': 'Consider maintaining plasma lithium levels at 0.8 to 1.0 mmol per litre for a trial period of at least 6 months for people who:, and have had a relapse while taking lithium in the past or or, and are taking lithium and have subthreshold symptoms with functional impairment.'}, {'original_recommendation_number': '1.10.17', 'heading_context': '1.10 How to use medication > Using lithium > Starting lithium', 'original_recommendation_text': 'Advise people taking lithium to:, and seek medical attention if they develop diarrhoea or vomiting or become acutely ill for any reason, and ensure they maintain their fluid intake, particularly after sweating (for example, after exercise, in hot climates or if they have a fever), if they are immobile for long periods or if they develop a chest infection or pneumonia, and talk to their doctor as soon as possible if they become pregnant or are planning a pregnancy.'}, {'original_recommendation_number': '1.10.17', 'heading_context': '1.10 How to use medication > Using lithium > Starting lithium', 'original_recommendation_text': 'Advise people taking lithium to:, and seek medical attention if they develop diarrhoea or vomiting or become acutely ill for any reason, and ensure they maintain their fluid intake, particularly after sweating (for example, after exercise, in hot climates or if they have a fever), if they are immobile for long periods or if they develop a chest infection or pneumonia, and talk to their doctor as soon as possible if they become pregnant or are planning a pregnancy.'}, {'original_recommendation_number': '1.10.18', 'heading_context': '1.10 How to use medication > Using lithium > Starting lithium', 'original_recommendation_text': 'Warn people taking lithium not to take over-the-counter non-steroidal anti-inflammatory drugs and avoid prescribing these drugs for people with bipolar disorder if possible; if they are prescribed, this should be on a regular (not when required) basis and the person should be monitored monthly until a stable lithium level is reached and then every 3 months.'}, {'original_recommendation_number': '1.10.20', 'heading_context': '1.10 How to use medication > Using lithium > Monitoring lithium', 'original_recommendation_text': 'After the first year, measure plasma lithium levels every 6 months, or every 3 months for people in any of the following groups:, and older people, and people taking drugs that interact with lithium, and people who are at risk of impaired renal or thyroid function, raised calcium levels or other complications, and people who have poor symptom control, and people with poor adherence, and people whose last plasma lithium level was 0.8 mmol per litre or higher.'}, {'original_recommendation_number': '1.10.20', 'heading_context': '1.10 How to use medication > Using lithium > Monitoring lithium', 'original_recommendation_text': 'After the first year, measure plasma lithium levels every 6 months, or every 3 months for people in any of the following groups:, and older people, and people taking drugs that interact with lithium, and people who are at risk of impaired renal or thyroid function, raised calcium levels or other complications, and people who have poor symptom control, and people with poor adherence, and people whose last plasma lithium level was 0.8 mmol per litre or higher.'}, {'original_recommendation_number': '1.10.22', 'heading_context': '1.10 How to use medication > Using lithium > Monitoring lithium', 'original_recommendation_text': \"Monitor lithium dose and plasma lithium levels more frequently if urea levels and creatinine levels become elevated, or eGFR falls over 2 or more tests, and assess the rate of deterioration of renal function. For further information see NICE's guidelines on chronic kidney disease and acute kidney injury .\"}, {'original_recommendation_number': '1.10.23', 'heading_context': '1.10 How to use medication > Using lithium > Monitoring lithium', 'original_recommendation_text': 'When discussing whether to continue lithium, take into account clinical efficacy, other risk factors for renal impairment and cardiovascular disease, and degree of renal impairment; if needed seek advice from a renal specialist and a clinician with expertise in managing bipolar disorder.'}, {'original_recommendation_number': '1.10.24', 'heading_context': '1.10 How to use medication > Using lithium > Monitoring lithium', 'original_recommendation_text': 'Monitor the person at every appointment for symptoms of neurotoxicity, including paraesthesia, ataxia, tremor and cognitive impairment, which can occur at therapeutic levels of lithium.'}, {'original_recommendation_number': '1.10.24', 'heading_context': '1.10 How to use medication > Using lithium > Monitoring lithium', 'original_recommendation_text': 'Monitor the person at every appointment for symptoms of neurotoxicity, including paraesthesia, ataxia, tremor and cognitive impairment, which can occur at therapeutic levels of lithium.'}, {'original_recommendation_number': '1.10.25', 'heading_context': '1.10 How to use medication > Using lithium > Stopping lithium', 'original_recommendation_text': 'If stopping lithium, reduce the dose gradually over at least 4 weeks, and preferably up to 3 months, even if the person has started taking another antimanic drug.'}, {'original_recommendation_number': '1.10.26', 'heading_context': '1.10 How to use medication > Using lithium > Stopping lithium', 'original_recommendation_text': 'During dose reduction and for 3 months after lithium treatment is stopped, monitor the person closely for early signs of mania and depression.'}, {'original_recommendation_number': '1.10.30', 'heading_context': '1.10 How to use medication > Using valproate > Starting valproate', 'original_recommendation_text': 'Advise people taking valproate, and their carers, how to recognise the signs and symptoms of blood and liver disorders and to seek immediate medical help if any of these develop. Stop valproate immediately if abnormal liver function or blood dyscrasia is detected. Although the absolute values of hepatic enzymes are a poor indicator of the extent of hepatic damage, it is generally accepted that if these are persistently elevated to over 3 times the upper normal limit, continuing to rise or accompanied by clinical symptoms, the suspected drug should be withdrawn. Raised hepatic enzymes of any magnitude accompanied by reduced albumin or impaired clotting suggest severe liver disease.'}, {'original_recommendation_number': '1.10.34', 'heading_context': '1.10 How to use medication > Using valproate > Monitoring valproate', 'original_recommendation_text': 'Monitor sedation, tremor and gait disturbance carefully in older people.'}, {'original_recommendation_number': '1.10.37', 'heading_context': '1.10 How to use medication > Using lamotrigine > Starting lamotrigine', 'original_recommendation_text': 'Advise people taking lamotrigine to:, and contact their doctor immediately if they develop a rash while the dose of lamotrigine is being increased, and tell you if they are pregnant or planning a pregnancy.'}, {'original_recommendation_number': '1.11.1', 'heading_context': '1.11 Recognition and diagnosing and managing bipolar disorder in children and young people > Recognition and referral', 'original_recommendation_text': 'Do not use questionnaires in primary care to identify bipolar disorder in children or young people.'}, {'original_recommendation_number': '1.11.2', 'heading_context': '1.11 Recognition and diagnosing and managing bipolar disorder in children and young people > Recognition and referral', 'original_recommendation_text': 'If bipolar disorder is suspected in primary care in children or young people aged under 14 years, refer them to child and adolescent mental health services (CAMHS).'}, {'original_recommendation_number': '1.11.3', 'heading_context': 'Recognition and referral', 'original_recommendation_text': 'If bipolar disorder is suspected in primary care in young people aged 14 years or over, refer them to a specialist early intervention in psychosis service or a CAMHS team with expertise in the assessment and management of bipolar disorder in line with the recommendations in this guideline. The service should be multidisciplinary and have:, and engagement or assertive outreach approaches, and family involvement and family intervention, and access to structured psychological interventions and psychologically informed care, and vocational and educational interventions, and access to pharmacological interventions, and professionals who are trained and competent in working with young people with bipolar disorder.'}, {'original_recommendation_number': '1.11.9', 'heading_context': 'Management in young people > Mania', 'original_recommendation_text': 'Aripiprazole is recommended as an option in NICE technology appraisal guidance for treating moderate to severe manic episodes in young people with bipolar I disorder. For full details, see the guidance on aripiprazole (TA292, 2013).'}, {'original_recommendation_number': '1.11.9', 'heading_context': 'Management in young people > Mania', 'original_recommendation_text': 'Aripiprazole is recommended as an option in NICE technology appraisal guidance for treating moderate to severe manic episodes in young people with bipolar I disorder. For full details, see the guidance on aripiprazole (TA292, 2013).'}, {'original_recommendation_number': '1.11.14', 'heading_context': 'Management in young people > Bipolar depression', 'original_recommendation_text': 'If there is a risk of suicide or self‑harm or any other risk outlined in recommendation 1.3.5 , carry out an urgent review and develop a risk management plan as outlined in recommendation 1.4.1 .'}])\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def compile_next_question_or_answer():\n",
        "    \"\"\"\n",
        "    tbc\n",
        "    \"\"\"\n",
        "\n",
        "    patient_schema_null_fields = # Compile list of missing information\n",
        "\n",
        "    if patient_schema_null_fields == None:\n",
        "        print(f\"I may be able to improve the answer if you give me information about one or more of the following: {patient_schema_null_fields}\")\n",
        "\n",
        "    # must record history of decisions taken for audit\n",
        "    write to file\n",
        "\n",
        "    return"
      ],
      "metadata": {
        "id": "niYj51LZcjYt"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def give_response:\n",
        "    compile_next_question_or_answer()\n",
        "\n",
        "    # Needs to deliver the original text of the recommendations somewhere (in a side bar?)\n",
        "    print(relevant_recommendations)\n"
      ],
      "metadata": {
        "id": "ZQZrDO5VWSmr"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def update_patient_dict():\n",
        "    \"\"\"\n",
        "    - what is known about the \"patient\" object\n",
        "    - history of questions asked and user answers, or is this in the UI?\n",
        "    \"\"\""
      ],
      "metadata": {
        "id": "i99Afg6ucicF"
      },
      "execution_count": null,
      "outputs": []
    }
  ]
}